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comparison of Virulent and Avirulent Legionella 
pneumophila and Evaluation of Fish as a 
Potential Reservoir/ Experimental Model 
Abstract 
A dissertation submitted in partial fulfillment of the 
requirement for the degree of Doctor of Philosophy 
at Virginia Commonwealth University 
Sandra R. Sommer, Ph.D. 
Medical College of Virginia - Virginia Commonwealth 
University , 1987 
Major Director: Dr. Harry P. Dalton 
Legionella 2_!±eumophil~ was first recognized as a 
cause of human pneumonia in 1976 . Since then, much has 
been learned about the microbiology, pathophysiology and 
epidemiology of this organism. The features which 
permit one strain but not another to invade human lung 
tissue and produce disease remain incompletely 
understood. This study e valuated several attributes of 
a virulent and an avirulent strain of 1~ pneumophila in 
an attempt to identify characteristics which would 
distinguish the two. 
Evaluation of a new medium, buffered egg yolk agar, 
showed that virulence was maintained after 26 passages, 
which was the same as the buffered charcoal yeast 
extract agar used for comparison. However, growth 
appeared earlier and was heavier on the charcoal-
containing medium. 
Morphologically, the avirulent strain produced 
greater numbers of filamentous forms and was found to be 
encapsulated more frequently. Treatment with polymixin 
B produced morphologic changes similar to those 
previously reported but failed to alter the virulence of 
either strain. No plasmids were found in either strain 
nor were consistent differences in protein content 
demonstrated using sodium dodecylsulfate polyacrylamide 
gel electrophoresis. Both strains reacted less 
intensely as cultures aged with a monoclonal but not a 
polyclonal antibody in a direct fluorescent antibody 
assay . This change was more pronounced when the 
virulent organism was tested. 
Chemotactic assays showed similar tendencies when 
human or guinea pig mononuclear cells were compared to 
two estuarine species (hogchoker and spot) and one 
freshwater species (golden shiner minnow) of fish. In 
vivo results were also similar when two of the three 
species of fish were tested, suggesting that either the 
spot or the minnow may be used in evaluation of certain 
characteristics of 1_,_ pneumophila. 
Organisms were isolated from apparently healthy 
fish up to 15 days after inoculation in some instances. 
This suggests that fish may be a possible additional 
environmental reserv oir for Legionella pneumophila. 
INTRODUCTION 
The Bellevue-Stratford Hotel in Philadelphia was 
t he site of the 58th annual convention of the American 
Legion, Department of Pennsylvania, July 21-24, 1976. 
I t was also to become famous as the site of the first 
r ecognized epidemic of what is now known as 
Legionnaires ' Disease (LD}, since most of the cases 
occurred in those who had attended the convention (121, 
201). Symptoms typically developed 7 days after the 
Legionnaire had arrived at the convention and became 
s evere enough that 147 of the 182 patients (81%) 
r equired hospitalization . Pneumonia was the major 
cl inical finding with death occurring in 16% a median of 
7 days after the onset of illness. Those who recovered 
s h owed radiographic evidence of improvement about 10 
day s after onset of illness with a more rapid clinical 
i mprov ement (121). 
The widespread publi c ity this epidemic received led 
t o a n i n t ensive search for the etiologic agent. Tests 
fo r known bacteria, fungi, chlamydiae, rickettsiae and 
v iruses were negative . Approximately 6 months after the 
i nitial outbreak, McDade and Shepard from the Centers 
for Disease Control (CDC) announced that a previously 
u nrecognized bacterium had been isolated from lung 
tissue from patients from the Philadelphia epidemic 
using guinea pig inoculations (263). This organism was 
found to be an aerobic gram-negative bacillus which, on 
the basis of extensive biochemical testing including 
guanine plus cytosine content and DNA hybridization 
studies, was determined to belong to a new species for 
which the name Legionella pneumophila was proposed (41, 
207). 
Serologic testing revealed that two previous 
outbreaks of undiagnosed illness, one which occurred in 
1965 in Washington, D.C. (290) and the other in Pontiac, 
Michigan in 1968 (132, 176) were in fact due to 1-.,_ 
pneumophila. McDade et al. (207) also demonstrated that 
the organism was involved in isolated cases over a wide 
geographic area in the United States. Later, a 
rickettsia-like agent (OLDA) originally isolated in 1947 
from guinea pigs inoculated with the blood of a patient 
with an upper respiratory tract infection was shown to 
be the same species (205). 
Much has been learned since this organism was firs t 
described . It is unusual in its biochemical composition 
and is one of the few bacteria which are c lassified as 
facultative intracellular parasites. It appears to be a 
fastidious organism in its growth requirements in the 
l aboratory and yet is ubiquitous in the environment . 
There are currently 23 species recognized with possibly 
11 more to be named (38). 
2 
Two forms of disease are described (14). The first 
is the pneumonia originally associated with it; the 
second is an acute, febrile self-limited disease known 
as Pontiac fever. Cases are more common in the summer 
months (99, 190, 305) and nosocomial pneumonia, 
especially in the immunocompromised patient, is frequent 
(146, 181, 210, 214). The disease and the bacterium now 
have been reported from many areas of the world. 
outbreaks have been associated epidemiologically with 
cooling towers (70, 79, 127, 183, 213), evaporative 
condensers (70), and potable water, especially hot water 
tanks (12, 34, 115, 146, 270, 281, 310, 343). 
Although many questions have been answered 
concerning Legionella pneumophila, much remains to be 
done. There is currently no acceptable, reasonably easy 
way to determine which of the many strains found in the 
environment is most likely to cause disease. Epidemics 
of nosocomial LD have been reported in association with 
a variety of environmental isolates, only 1 or 2 of 
which were consistently isolated from patients. On the 
other hand, other institutions have isolat ed legionellae 
in various water sourc es with apparently l ittle 
associated disease ( 72 , 77, 120, 316) . Controversy 
exists as to whether it is necessary to eradicate t h e 
organism in this situation. If a simple test were 
available to determine virulence o f the v arious 
isolates, this decision would be easier to make. 
3 
Several factors associated with virulence in other 
bacteria have been found in the Legionellaceae, 
including endotoxin-like activity (166, 336), hemolysin 
(9, 125, 301), phospholipase C activity (8), and several 
proteases (13, 20, 82, 218, 300). Which, if any, of 
these is necessary for virulence is unknown. Some 
researchers have associated the presence of plasmid(s) 
with decreased virulence (29, 47) and 1-.,_ pneumophila is 
known to lose its ability to cause disease after 
continuous passage on a variety of artificial media (33, 
103, 206, 338). Others have shown a relationship with 
certain monoclonal antibody reaction patterns (169, 236, 
306, 319). 
Another question relates to the ability of the 
organism to cause 2 distinct diseases, LD and Pontiac 
fever. The isolates from an outbreak of each type were 
indistinguishable in experimental infections induced in 
guinea pigs (161). There is also one report of both 
diseases occurring after a common-source exposure (130). 
Legionella pneumophila is commonly found in the 
environment. It has been associated with blue-green 
algae (303), green algae (162), several species of 
amoebae (1, 10, 155, 224, 258, 309) and ciliated 
protozoans (10, 113), all ubiquitous in water. These 
may account for the growth and survival of 1-.,_ 
pneumophila in many instances, but not all. There has 
been little work reported concerning other possible 
4 
ampli fiers and/ or reservoirs in the environment. 
survival mechanisms employed by this fastidious (in the 
laboratory) organism are still unclear. The seasonal 
occurrence of disease is also unexplained, but may be 
due t o increased virulence in the summer months. 
the r eason for this change is unknown . 
If so, 
5 
LITERATURE REVIEW 
Clinical Disease 
Two types of disease are associated with the 
Legionellaceae. Most common is the pneumonic form seen 
in the original 1976 epidemic and known as Legionnaires ' 
Di sease. The other has been reported less frequently 
and is an acute nonpneumonic illness, Pontiac fever. 
Other types of infections have been reported and the 
infection in children may cause symptoms different from 
those seen in adults (239) . 
Legi onnaires ' Disease (LD) 
This pneumonia is caused by Legionella pneumophila, 
mos t often serogroup 1 (245). Other spec i es may cause a 
clinically indistinguishable disease (Table 1), 
identified by the more general term, legionellosis, 
whi ch refers to all clinical syndromes produced by 
organisms classified within the genus Legionella (14). 
Pneumonia caused by 1__,_ micdadei is the only other type 
whi ch has been characterized and i s s i milar to that 
c aused by 1__,_ pneumophila (216). Smaller numbers of 
infections by other species have been reported but there 
is no evidence that unique clini c al manifestations are 
p roduced (14) . 
LD appears to be a relatively common pneumonia 
6 
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which may be underdiagnosed, especially in institutions 
where this diagnosis is not specifically and 
conscientiously sought. Macfarlane et al . (197) found 
15% of community-acquired pneumonia to be due to 
Legionellaceae; this was the second most common cause in 
their prospective study conducted in England. Nearly 
50% of patients admitted with pneumonia during July, 
Augu s t and September were found to hav e LD. Muder et 
a l. (214) in a similar study , found that in a community 
t eaching hospital in the United States where LD had 
never been doc umented, 9.5% of all pneumonias and 14.3% 
of nosocomial pneumonias were caused by Legionellaceae . 
Their study was conducted in February, April, and June, 
months in which the incidence of LD outbreaks is lower 
(99 , 190) so these rates c ould be e v en higher if other 
months were evaluated. Ini tiall y, reported cases were 
as s oc iated with outbreaks, but a s urvey by England et 
a l. ( 105) indicated that sporadic LD was twice as 
frequ ent, and Sanford ( 2 63) suggests that LD comprises 
4-1 0% of all sporadic pneumonias. 
The incubation period for LD appears t o range f rom 
2-11 day s (121, 290) although an app arent incubati on of 
28 days has been reported (181). The patient then 
t ypically experiences a period of mala i se, diffus e 
myalgias and headache followed in 12-48 h by sudden 
onset of high nonremittant fever a nd recurrent shaking 
chills . Gastrointestinal symptoms (nausea, v omiting, 
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watery diarrhea) may then occur, followed by a 
nonproductive cough and dyspnea (283). The disease may 
progress to respiratory failure requiring mechanical 
ventilatory assistance, hypotension and death (181, 
307). Renal dysfunction and encephalopathy are also 
frequent (148, 283). Clinical manifestations are 
usually not distinctive enough to allow differentiation 
from other causes of pneumonia, although unexplained 
encephalopathy and hematuria were found to be suggestive 
in one study (148) while these plus diarrhea were 
frequent in two others (180, 272). Hyponatremia was a 
useful distinguishing feature in a study by Miller 
(2 11), but this was not the case in the work of Sharrar 
et al. (272). Macfarlane et al. (196) found no 
distinctive radiographic features when 49 sporadic cases 
of LD were compared to 147 cases of pneumococcal, 
mycoplasma or psittacosis pneumonia. Reported fatality 
rates vary from 8-25% (44, 78, 121, 145, 180, 183, 190, 
290 ) although this may improve with more rapid diagnosis 
and treatment (202). Factors associated with increased 
risk of LD include sex (male), age ( ~ 50 yrs.), smoking, 
underlying malignancy, immunosuppressiv e drug therapy, 
diabetes mellitus, and increased a lcoho l consumpti on 
(105, 190, 279). Treatment with erythromycin alone or 
with rifampin is effective (14, 121, 181). Tetracycline 
appears to be less effective and trimethoprim-
sulfamethoxazole may have been effective in a few cases 
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(181). 
Pontiac Fever 
This form of legionellosis is characterized by the 
abrupt onset of fever, chills, headache, and myalgia 
(132). Cough is uncommon and the illness is similar to 
influenza and may be indistinguishable from a variety of 
respiratory syndromes induced by v iruses (14). In 
contrast to the 0.4-4% attack rate associated with LD 
(181), 95% were affected in the first reported outbreak 
of Pontiac fever (132). Other differences include a 
shorter incubation period (mean, 36h), the absence of 
pneumonia, and it is a benign self-limited illness 
last ing 2-5 days (132) . The Pontiac, Michigan outbreak 
was caused by h pneumophila, serogroup l, but an 
outbreak in Windsor, Ontario, was shown to be caused by 
h feeleii (150). This outbreak was clinically simi~ar 
to that caused by h pneumophila (149). There i s one 
reported instance of simultaneous occurrence of LD and 
Pont iac fever in Vermont (130) but only one case of each 
was .s een. 
Othe r Infections 
Several unusual findings have been reported in 
assoc iation with LD, including p yelonephritis (80), 
acute interstitial nephritis (268), intractable seizures 
(240), peritonitis (271), and pericardial effusion 
(27 1). Rarely, legionellae have been associated with 
infection in the absence of pneumonia. Pericarditis 
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(22 3), prosthetic valve endocarditis (204), sinusitis 
(2 65), and perirectal abcess (5), and possibly acute 
pancreatitis (4) have been reported. Infection of a 
hemodialysis fistula occurred in 2 patients, one with 
concurrent LD and another who had completed erythromycin 
therapy for LD 3 weeks earlier (173). Another patient 
pre s ented initially with pericarditis and dev eloped 
ocular involv ement; only after more than 2 weeks did 
pu lmonary findings develop (123). Pastoris et al. (239) 
h av e suggested that in children infection may take the 
fo rm of cardiac arryhthmia or myocarditis witpout 
pneumonia. Typical LD is uncommon in children (2, 14). 
Pathologic Findings 
Consistent pathologic findings in fatal LD are 
limited to the lung. Macroscopically, the lungs are 
he av y with varying deg rees o f consolidation, usually 
b i l ateral, and no predilec tion f o r any one lobe (334) . 
Abcesses appear to be rare, with only 2 instances noted 
in 42 cases reported (28, 334). 
Microscopically, the histologic pattern is that of 
an acute fibrinopurulent pneumonia . Th ere is extensive 
exudation of neutrophils ( PMN), macrophages , and f ibri n 
into the alveolar spaces . In s ome cas es there is 
extensive lysis of the i nflammatory cells, but this is 
no t uniformly distributed within the lung. The 
underlying lung structure remains relatively uninv olved; 
t he inflammatory process has no t been noted to involve 
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blood vessel walls or large bronchi (27, 28, 334). 
Erythrocyte extravasation into the alveoli varies . Most 
sections have none or only a few; but areas of moderate 
to severe hemorrhage are occasionally present (27). 
Chandler, Hicklin, and Blackmon (55) originally 
reported the unusual staining properties of the 
organism. It stains faintly or not at all with the 
usual tissue stains for bacteria, but is v isualized 
using the Dieterle silver impregnation method. The 
organisms are seen within the pneumonic process using 
this method, with higher numbers associated with 
necrosis of the inflammatory cells (28, 334). They 
appear as short, pleomorphic rods 2-4 um in length and 
up to 1 um in diameter. Some appear to be bipolar and 
beaded forms may be seen. Clusters are commonly 
observed within macrophages as well as extracellularly 
(55). Alveolar damage, if it is seen , is most likely 
due to treatment (oxygen therapy) or is a nonspecific 
reaction to sepsis or shock (53, 151). Surgical 
specimens may show changes similar to those seen at 
autopsy; however, the organism may no t be seen (55). 
Laboratory Identification 
The laboratory may aid in the evaluation of both 
clinical and environmental sources of legionellae. The 
organism or its soluble products may be detected 
directly in the specimen or by isolation of the bacteria 
by culture methods. Serologic diagnosis also may be 
made in the case of clinical infection by demonstrating 
a four-fold change in antibody titer or by a single high 
titer. 
Direct Examination of Specimens 
Cherry and co-workers (60) first described the use 
of a direct immunofluorescent assay (DFA) to detect 
organisms in lung tissue samples. Initially, Broome et 
al. (43) found that of patients shown to have LD by 
other criteria, only 24% also had DFA positive sputum 
samples. They suggested that the more invasive lung 
biopsy might be necessary in order to demonstrate the 
organism by DFA . More recent work has proven the value 
of testing respiratory secretions using DFA (93, 246, 
333) with bronchial and tracheal secretions having a 
positivity rate almost as high as lung specimens (246). 
Unfortunately, while the specificity is about 99% (87) 
the sensitivity of DFA testing, as compared to culture 
diagnosis, ranges from 25 to 70% with 60% the average 
(88). The lower limit of detectability in seeded sputum 
using DFA is about 10 4 organisms per ml (135). DFA 
testing is becoming impractical with the increasing 
number of species and serogroups. One group (48) has 
evaluated an indirect fluorescent antibody system using 
a panvalent antibody pool and labeled goat anti-rabbit 
antibody with promising results. Most of these studies 
evaluated reactions with .!;_,_ pneU)T!Qp_l]._:i,_J_g_ serogroups, but 
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s imilar findings have also been reported for .!:_,__ micdadei 
( 71 , 331). Monoclonal antibodies have been prepared by 
s e veral groups (49, 133, 137, 236, 269, 318, 167) all 
are species-specific and most are also specific for 
s erogroup. Studies have shown that reactivity is 
equivalent to the polyclonal reagents available (90, 
289 ) . Since most LD is caused by.!:_,__ pneumophila 
s erogroup 1 and there is evidence that these monoclonal 
antibodies do not cross-react as the polyvalent 
occasionally has been reported to do (95, 174, 233, 289) 
they may be more useful. 
Soluble Legionella antigens hav e been detected in 
urine using radio- and enzyme-immunoassay techniques 
(19, 25, 186, 187, 188, 285, 302) and reverse passive 
agglutination (200, 284); staphylococcal coagglutinati on 
h as also been suggested (326). Lower amounts of antigen 
have been detected in serum (25) and it h as been 
suggested that antigen detection c ould be useful in 
evaluating other tissues and body fluids (111, 302) 
Another promising tool for rapi d detecti on of t h e 
organism in clinical materia1 is the recent ly developed 
nuc leic acid probes (92, 106, 13 6 , 18 9) . 
Environmental water samples have been teste d us ing 
DFA as described by Morris and c o -workers (213) and 
modified by Orrison, Cherry, and Milan (234) . These 
specimens require concentration by filtration or 
c entrifugation and DFA then has been shown to detect > 
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105 organisms/ml (234) . It must be remembered, however, 
t h at DFA originally was developed .for clinical specimens 
and only L. pneumophila serogroups 1-4 have been 
extensively evaluated for cross-reactions, so caution is 
r e quired in interpreting DFA data in the absence of 
cultures. Electron-capture gas chromatography has been 
suggested for detection in water specimens (129) . 
Presently, culturing samples appears to be the most 
widely used technique, alone or together with DFA. 
Iso lation Methods 
McDade and co-workers (207) initially isolated k,_ 
pne umophila in guinea pigs inoculated intraperitoneally 
wi t h tissue suspensions from fatal cases occurring 
during the 1976 Philadelphia outbreak. Tissues from 
infected guinea pigs were lethal for 6-7 day old 
embryonated hens ' eggs. The organism did not grow on 
trypticase soy or blood agar or in thioglyco llate broth. 
It was cultured successfully on Mueller-Hinton (MH) agar 
containing 1% hemoglobin and 1% IsoVitaleX (Incubated i n 
a 5% co2 atmosphere) from both infected material 
obtained in laboratory experiments as well as from the 
ori g inal human tissues . I t al so h a s been shown t o grow 
on c ommercially enriched c hocolate a gar (8 4 ). 
Analysis of this modif i ed MH agar revealed that L-
cys teine HCl could substitute for t he IsoVitaleX and 
fe rric pyrophosphate for the hemoglobin (110). This 
medium, Feeley-Gorman agar, was f u rther modified by the 
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addition of yeast extract as a protein source and 
activated charcoal to remove inhibitors produced during 
preparation (109, 154) . This charcoal yeast extract 
agar (CYE), further modified by the addition of a 
buffer, N-(2-acetamido)-2-aminoethane sulfonic acid 
(ACES), and a -ketoglutarate (BCYE), has resulted in 
enhanced growth of legionellae (85, 237) The pH of the 
medium is important, and should be adjusted to 6.9 using 
KOH, as NaOH has been shown to be inhibitory (109). 
BCYE is satisfactory for specimens which normally 
are expected to be sterile (177) but the slow-growing 
legionellae often are inhibited or masked when 
contaminated specimens such as sputum or environmental 
samples are cultured. Glycine has been shown to be an 
effective selective agent by Wadowsky and Yee (315). 
Antibiotics have been added in various combinations (30, 
85, 94) as well to improve the ability to isolate 
legionellae from contaminated specimens. Comparative 
studies have demonstrated the effectiv eness of these 
media for clinical specimens (50, 85, 97) although 
strains of!:_,_ micdadei, !:_,_ gormanii, !:_,_ dumoffii, and 
possibly other species may be inhibited by some 
components (315). 
Pretreatment of contaminated specimens using heat 
(97), low pH (30, 50), or negative enrichment (299), has 
been suggested with acid pre-treatment resulting in 
greater enhancement with clinical specimens, especially 
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when used with a semi-selective medium (SO, 97). When 
c ompared with DFA, culture is more sensitive for 
.ko_ pneumophila by a factor of 1.2 to 4 (50 , 87, 88). 
Results with environmental samples are mixed (30, 52, 
76, 85, 86, 98). Direct plating methods are generally 
agreed to be superior to the original guinea pig 
inoculation method (76, 98) but it appears that 
p retreatment, concentration, or use of selective medi a 
ma y all reduce the number of organisms recovered and/ or 
t he species isolated (52, 85, 314). Thus, no single 
selective medium or pretreatment method can be used 
exclusively , and most environmental samples will 
' probably require a combination of several techniques fo r 
maximal recovery of legionellae. 
Identification of Isolates 
Presumptive identification at the genus level* can 
be made if after 3 to 5 days of incubation, small (1 -2 
mm in diameter) colonies of pleomorphic gram-negativ e 
bacilli appear on BCYE but not on media without L-
cysteine (e.g., trypticase soy blood agar or BCYE made 
without it). After s everal days of growth , the colonies 
*Thr e e genera in the fami l y Legi o ne lla c eae h av e been 
prop o sed: Legionella, Tatlockia, and Fluo~ibacter (45 , 
128) . The issue remains controversial (38). This work 
r efers to the organisms using the one genus 
( Legionella), classification system as described by 
Brenner et al. (40, 41). 
become larger, more convex, and finally flatten out 
(87 ). Two non-Legionella organisms which might be 
mi sidentified by this growth test are a thermophilic 
Bacillus sp. (291) and Francisella tularensis (198). 
These can be distinguished by the ability to grow at SSC 
(Bacillus) or by colonial morphology , growth rate and 
carb ohydrate utilization (_L_ tularensis) . 
Speciation of the legionellae is more difficult 
(Table 2). All species fail to produce acid from 
glucose, reduce nitrate, or produce urease. It has been 
said that all species produce catalase (38); however, 
Pine and co-workers (242) have shown that L. pneumophila 
do es not actually produce catalase. Instead, this 
spe c ies produces only a peroxidase with weak catalase-
like activity. Pine et al . (242) described a who l e-cell 
peroxidase test which can distinguish b_,_ pneumophila 
from the other species. b_,_ oneumophila i s also the only 
spe c ies whi c h hydrolyzes sodium hippurate (140) althou gh 
some str ains of b_,_ feeleii and b_,_ spiritensis also may 
be weak ly p o sitive (40). b_,_ mi cdadei has been shown to 
be ac id-fas t in t issu e (2 2 1, 2S6 ) although it ma y l o se 
this characteristic when grown on BCYE (1S 2 ). 
Auto fluorescence and browning on media containing 
tyro s ine (but not charcoal) also have been used to 
identify species (312). Vickers, Brown, and Garrity 
(31 1) have developed a dye-containing differential 
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Table 2 
Phenotypic Ch.aractariatica of tha 23 Knowu Species of Lei1onella* 
Gelatin Hippurate Beta 
Spe c ies Ca ta l asa Browning l liguefaction hi:droli:&is Motility ~ l actamase 
2neumo2hila -2. 3 + + + + + or +/ - + h· 
h ~ 
+ (w) 
+/ - + 
SEi r itensia + + + 
(w) 
+ + + h· 
h longbeachae + + + + + +/ -
h· Jo rdanis + + + + + 
h· oak.r id31ensis + + + 
+ (w) 
h· •.Jadswo rthii + + + + 
!,_. sainthelensi + + + + + 
h· ~ + ( w) + + + + 
h· maceachernii + + + + 
h jam.es towniens is + + + + + 
h santicr ucis + + + + + 
h· ~ + + 
h· israelensis + +(w) ND 
h· bozemanii + + + + + / - +/ -
h· dumoffii + + + 
h· gormanii + + + + + 
h· ~ + + + + 
h· cherrii + + + + + 
b steigen.1altii + + + 
h :earisiensis + + + 
h rubriluc.ens + + + 
h erytnra + + + + + 
. Data from re fs LS an d 40 
r~ must be noted that.in some cases reaccions are based on one or ~nly a few .s tratn.s and 
tna.y be modi!"ied in the futu re 
1 b r owning produced o n c ha r- -:.:ial-treated yeas t ext r a c t agar .:on t aining tyro s i ne 
• ~ positive ; - • ne gative; + (w) • '"'eak reaction; +/ - • 'Weakiy o r not always positive; 
~D ,. no t done 
3 
.h· pneumophila p r oduces a peroxidase tJ ith weak ..:.a talase- like a ctivity ( see text ) 
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medium which is probably very useful in their 
institution where both.!;_,_ pneumophila and.!;_,_ micdadei 
a r e endemic (216). It is not likely to be cost 
effective in other settings. It must be noted that 
biochemical reactions in some cases are based on a 
single strain or only a very few strains, and these 
reactions may be modified as more are isolated (38). 
Clinically, serogrouping is the most useful way to 
distinguish species (87). This may be done by DFA (60, 
71, 288), agglutination (292, 293, 295, 325) or possibly 
counterimmunoelectrophoresis (275). There is some 
cross-reactivity among species and, rarely, other genera 
( 16 , 24, 95, 165). An isolate which fails to serotype 
stil l has a high likelihood of being Legionella (either 
a n ew serogroup or species) (87). DNA hybridization 
studies, impractical for the clinical laboratory, may be 
necessary for definitive identification of species (3 8) . 
Se rologic Diagnosis 
Serologic testing by McDade et al. (207) during the 
1976 Philadelphia outbreak determined that a 4-fold 
increase in titer to a minimum of 1:64 or a single t i ter 
> 1:128 using an indirect fluores c ence assa y (IFA) c ould 
be associated with disease. Studies o f titers in 
apparently healthy populations (147, 264, 280) led the 
CDC to modify these values to a 4-fold increase to at 
least 1:128 or a single titer of at least 1:256 for.!;_,_ 
p neumophila serogroup 1 antibodies (324). The incidence 
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of antibodies to other species is less well-defined 
although recent studies suggest that prevalence may be 
higher for at least some species than for 1_,_ pneumophila 
(32, 321, 328). 
Titers described above were obtained using a heat-
killed organism as the antigen in the IFA. Several 
other methods have been described for preparing the 
antigen (15, 230, 238, 287) which have been shown to 
result in lower titers but, if the titer which is used 
to determine infection is also lowered, these methods 
are equivalent in sensitivity (107, 323). In order to 
interpret titers accurately, the type of antigen must be 
known. Another problem in interpretation results from 
the fact that some patients develop species-specific 
antibodies (45% in one study [328]) while others appear 
to react with a common antigen (55% [328]) so that no 
single antigen could be used to detect all Legionella 
infections. 
Cross-reactivity of Legionella with other organisms 
appears to be uncommon . Early concerns about Mycoplasma 
oneumoniae cross-reactivity (134) appear to have been 
discounted (247, 322). Rarely, s era have been shown to 
cross-react with certain strains of Bacteroides fragilis 
(95), Hemophilus influenzae and Staphylococcus aureus 
(172) and Chlamydia psittaci (232). Patients with 
antibodies to 1_,_ bozemannii have been shown to have 
similar serological reactivity with Rickettsia typhi and 
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fro teus vulgaris OX19 (276). 
other methods, which are either easier to use or 
can be automated have been described and may overtake 
the IFA in popularity . A microagglutination assay was 
described in 1978 by Farshy, Klein and Feeley (108) 
which has been shown to be useful (68, 139, 185, 286). 
A limitation of this procedure is the cross-reactivity 
of agglutinating antibodies with species of Pseudomonas 
(69 , 184 ) . Collins and associates (69) reported that 
cystic fibrosis patients often had elevated titers to 
Legionel la antigens (41.3% of the 128 patient samples 
tested had titers ~ 1:64 to one or more as compared to 
9 7% of 103 normal controls) . These titers correlated 
directly with those to f_,_ aerugi_gQ_s a, a common cause of 
infection in these patients. In another study (66), 
this same group used crossed immunoelectrophoresis to 
demonstrate that 1-.:_ pneumophila possessed an antigen 
related to the "common antigen" of f._,_ aeruginosa . This 
cross-reactivity is found in several species of 
Legionella, but is highest with 1-.:_ bozemanii (69) . 
Enzyme-linked immunosorbent assay has also been 
used for antibody detection (100, 108, 262) and a solid-
phase immunof luorescence assay has recently been 
reported (26, 298). Indirect hemagglutination (193, 
341) , and immunodiffusion (277) have also been eva luated 
and found to be useful. Rodgers and Laverick (253) have 
tested a passive hemagglutination assay using flagellar 
22 
23 
antigen-coated turkey erythrocytes which may be useful 
in d etecting antibodies to those Legionella species 
which are flagellated (the majority). Sampson, 
Plikaytis, and Wilkinson (261) recently have shown that 
a 58 kilodalton (Kdal) protein common to all 7 species 
and 8 serogroups tested reacted with sera from 100% of 
patients with culture-confirmed LD (1_,_ pneumophila 
serogroup 1) and 78% of those which were diagnosed 
sero logically. This may lead to a test which is able to 
detec t most species associated with human disease 
without the occasional cross-reactivity seen in assays 
currently in use . 
Pathogenesis 
Investigations of the ability of legionellae to 
cause disease were initially hampered by the lack of an 
appropriate animal model . McDade et al . (207) 
originally isolated the organism by intraperitoneal 
inoculation of guinea pigs but the pathologic lesions 
did not resemble those seen in human LD (56, 332) . 
Since it seems likely that humans are infected by the 
respi ratory route, v arious experimental models have been 
deve loped using this means to induce infection. 
Intranasal and intratracheal instillation are analagous 
to aspiration of oropharyngeal contents which may be an 
important mechanism in the development of nosocomial LD 
in the compromised host. Guinea pigs and rats have been 
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infected by these methods but there are drawbacks (332). 
Exposure to concentrated bacterial aerosols is most 
similar to the ways humans may acquire the disease in 
the community. Whole body aerosols have been used with 
guinea pigs (22, 176, 209, 217) but many organisms wind 
up in body fur as well as in the lungs (332). Several 
investigators have used snout-only aerosol exposure to 
produce infection in several animal species, including 
guinea pigs, rats, mice, marmosets, and monkeys. Guinea 
pigs are moderately susceptible to disease but rats and 
monkeys are more resistant and mice appear to be very 
resistant to pneumonia when inoculated this way. 
Lesions produced in this manner appear to be similar to 
and mimic human disease rather well (332). 
Once an animal model had been developed, it became 
possible to evaluate a variety of potential virulence 
mechanisms in vivo as well as in vitro. Virulence may 
be a result of physical attributes, the production of 
soluble toxic factors, or the ability to avoid or affect 
host defense mechanisms. Legionella appears to possess 
capabilities in all these areas, but a most important 
factor in producing disease well may be its ability to 
multiply intracellularly within monocytes and 
macrophages. Each of these aspects will be discussed in 
more detail below. 
Ultrastructure 
The legionellae have been studied using human lung 
tissue, and organisms grown on various types of 
arti ficial media and in the yolk sac of fertile hens ' 
eggs . The organism is ultrastructurally similar in all 
preparations, with exceptions as noted below. 
In an early report, Rodgers, Macrae, and Lewis 
(254) described the organism in tissue as a short cocco-
bacil lus (0.6 pm wide, 1-2 µm long) with parallel sides, 
tapered ends and a smooth surface. Vacuole-like bodies 
were evident and occasional organisms had a loose 
undu lating outer membrane. Most organisms were seen 
intracellularly in the cytoplasm of degenerating cells; 
none were found in the nuclei. 
These findings were confirmed and expanded in 
subsequent studies (54, 178, 250). Long forms and 
filaments 10-20 µm long were rarely seen in tissue but 
were seen in preparations from cultures on artificia~ 
medi a (54, 250). In 1984, Bornstein, Nowicki, and 
Fleurette (33) correlated the average lengths of 
organisms grown on various media with the LD 50 of the 
same form for embryonated hens ' eggs. They found that 
after 10 subcultures, the shortest forms, grown on 
embryonated egg yolk sacs, also had the lowest LD 50 
(10 1· 36 ) while the longest forms grown on BCYE, had the 
highest LD50 (10 4· 79 ). They suggest that increased 
numbers of filamentous forms may be associated with 
decreased virulence. In another study, Chan (Ph . D. 
thesis, Virginia Commonwealth Uni versity, 1982) 
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as sociated morphological changes produced by polymixin B 
treatment with increased virulence for guinea pigs. He 
al so noted increased vacuolation associated with 
vi rulence. 
Glavin et al. (131) observed an electron-lucent gap 
surrounding organisms in sections of human lung tissue 
and suggested that this might represent a microcapsule. 
Rodgers, using ruthenium red to detect the polyanions 
as sociated with capsules, detected none (250, 251). 
However, Hebert et al. (141) did observ e rare capsules 
in 1-_,_ pneumophila using ruthenium red . This discrepancy 
may be due to slight differences in t echnique, strain 
di fferences, or different growth conditions (255). 
Another area in which discrepancies were found in 
early studies involved the presence or absence of an 
electron-dense peptidoglycan layer, found in gram-
negative bacterial cell walls (54 , 117 , 178, 250). Keel 
and co-workers (178) saw no peptidoglycan structure on 
electron-microscopy, but did find typical components 
biochemically, wi t h the except ion o f the c ros s -linkin g 
ma t e r ial , diaminopimelic acid. Chandler et al. (54) d i d 
rep o r t its presence in thei r s t udy. The i mporta nce o f 
thi s feature is related to the endo toxi c properties of 
t he typical gram-negative cell wall. End o toxin activity 
a ssociated with legionellae is discussed more fully in 
t he next section. 
Early studies found no evidence o f flagella (54 , 
250). More gentle preparation techniques did lead to 
t he observation of flagella and pili by several groups 
( 57, 141, 252, 296). Most often organisms had a single 
polar or subpolar flagellum up to 8 um long. 
Occasionally pairs of polar flagella were seen. Many 
were straight, but gently curved as well as very curly 
fo rms were noted . The fact that not all strains had 
fl agella or pili would suggest that this is not 
important for virulence in Legionella spp. Elliott and 
Johnson (102) did report flagella on organisms known to 
be v irulent while none were found on those nonvirulent 
fo rms grown on artificial media. Later work by these 
same authors (103) showed that lack of flagella, while 
associated with growth on certain t ypes of media, was 
not associated with v irulenc e. Organisms grown on BCYE 
did not decrease in virulenc e and retained flagella 
after 12 passages. Organisms grown in yeast extract 
broth failed to produce flagella, but remained v irulent, 
at least for guinea pigs i n j ected intraperitoneally. 
Vi rulence Factors 
As mentioned abov e, g ram-negativ e bac terial cell 
walls are associated wi th a heat- s t ab l e 
lipopolysaccharide (LPS) t oxin (36). Wong and co -
workers (216) first demonstrated that 1-:_ pneumophila 
does exhibit "endotoxicity" but it diffe r s from the 
c lassic activity associated with gram-negative bacteria. 
It was weaker in a variety of endotoxicity tests and 
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reacted biochemically in an atypical fashion. I:_,_ 
pneumophila LPS has been shown to contain 2-keto-3-
deoxyoctonate (62, 126, 153, 336) as other gram-negativ e 
LPSs do, but does not contain heptose (235) or large 
amounts of hydroxy fatty acids. In fact, the 
legionellae possess primarily unique branched-chain 
fatty acids which are predominately unsaturated (114, 
203, 336). 
Outer membrane proteins also are important in 
bacterial virulence (274). Several groups have isolated 
a major outer membrane protein (MOMP) which appears to 
be species-specific (51, 153, 226). This MOMP has a 
molecular weight in the range of 24-30 Kdal (51, 126, 
153). Hindahl and Iglewski (153) characterized their 29 
Kdal MOMP as similar to that of the Chlamydiae. They 
suggested a possible role for this MOMP in the 
inhibition of lysosome-phagosome fusion (see below) 
which L. pneumophila and .Q_,_ psittici are both known to 
do. The fact that monoclonal antibodies apparently 
detect surface antigens which differ according to 
virulence (169, 236, 306, 319) also supports the 
invo lvement of membrane components in causing disease. 
Transmissible plasmids are known to confer 
antibiotic resistance and have been associated with 
toxin production in other bacteria (36) . Plasmids in 
varying numbers have been found in the legionellae. 
Most plasmids have been found primarily in environmental 
28 
29 
isolates while the majority of clinical isolates have 
been plasmidless (46, 47, 96, 199, 228), although a 
recent study conducted at the Wadsworth Veterans ' 
Administration Hospital in California found plasmids in 
95% of their clinical isolates (96). One group (29) has 
reported increased virulence with the plasmidless form 
associated with almost all the nosocomial LD cases seen 
in their institution . Both types tested were 
environmental isolates from the potable water system; 
the plasmidless organism had a lower LD 50 as determined 
by intraperitoneal inoculation of guinea pigs as well as 
a shorter time to death. While plasmid transfer into 
Legionella species has been reported (58, 179) as well 
as among Legionella species (81), it was difficult and 
probably is not a major virulence factor. 
Extracellular products c apable of producing tissue 
damage have been described. A hemolytic cytotoxin has 
been reported for several species (9, 125, 301). Thorpe 
and Miller (301) found no difference in activity in 
environmental, human, animal-passaged, and laboratory-
adapted strains, suggesting that this hemolysin is not 
sole ly responsible for conversion to avirulence. Baine 
(8) has demonstrated phosphol ipase C activity 
(associated in several bacterial species with hemolysis) 
which may explain at least partially the ability to 
damage erythorcyte membranes. Baine also suggests that 
thi s activity may inhibit lysosome-phagosome fusion . A 
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vari ety of aminopeptidases, esterases and proteases also 
has been reported (13, 82, 218, 219, 229, 300) including 
one protease which causes pulmonary damage in guinea 
pigs when administered intranasally or intratracheally 
(13). Another protease has been shown to have 
chymotrypsin-like activity (20). These proteases may 
produce pulmonary damage although major tissue-
destructive proteases other than the one described above 
(13) have not been detected with certainty. Another 
toxin has been shown to affect the metabolism of human 
neut rophils with no apparent effect on viability or 
phagocytosis (124). This may play a role in the ability 
of legionellae to survive intracellularly. Muller (220) 
ha s developed a system to test for inducible enzymes 
which may correlate with virulence. 
The fact that LD symptoms indicate multisystem 
invo lvement (renal, gastrointestinal, neurolog-ical) with 
the organism itself found only rarely outside the lung 
suggests that a toxin is important in causing disease. 
Legi onellae have been isolated fr om the blodd so the 
presence of bacteria in low numbers in other organs is 
possible as well (248). 
\ 
One problem in interpreting many of these studies 
r elating to extracellular products is the omission of 
passage history or determination of virulence of the 
organism(s) used. 1.__,_ pneumophila has been shown to lose 
virulence when passaged on artificial media (206) 
including BCYE agar (33, 163 2 313). Virulence is 
restored upon passage in cultured human embryonic lung 
fibroblasts (338) or in guinea pigs or embryonated eggs 
(103). Chan (Ph.D. thesis) recently has evaluated a 
buffered egg yolk medium which appears to maintain 
virulence longer than BCYE. If this is so, virulence 
studies would be simplified by the omission of periodic 
passage through living material in order to maintain 
virulence. 
Interactions with Phagocytic Cells 
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Intracellular organisms seen in histologic sections 
from lungs of patients with LD suggested that the 
abili ty to multiply within the cells found in lung was 
an important process in the ability of 1_,_ pneumophila to 
cause disease. Horwitz and Silverstein demonstrated in 
1980 (157) that the organism did indeed multiply 
intrace llularly in human monocytes but not in PMNs or 
lymphocytes. This also has been found to be true for 
human alveolar macrophages obtained by bronchoalveolar 
lavage (222). Tissue cultures of v arious cell lines 
including human embryonic lung fibroblasts also support; 
intracellular growth (73, 231, 337 ) and are more 
convenient and more easily obtained than the human 
monocyte/ macrophage. Various animal models, most often 
the guinea pig, also have been used to demonstrate 
simi lar findings in vitro. The ability to multiply well 
intracellularly has been associated with only the 
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virulent strains tested. The organisms lose this 
ability, which correlates with loss of in vivo 
virulence, when cultured on artificial media (101, 164, 
182). None of these studies found that b_,_ pneumophila 
could grow extracellularly under experimental 
conditions. The cells do not produce a soluble growth 
factor; the organism must find its way inside the cell. 
Phagocytosis of legionellae is characterized by 
several unusual findings. Horwitz (156) found that long 
phagocyte pseudopods coil around the organism as it is 
internalized; however, this was not seen by Oldham and 
Rodgers (231) or Elliott and Winn (104) . All agree that 
once internalized a novel phagolysosome is produced. 
Shortly after entry, most vacuoles are surrounded by 
smoo th vesicles and mitochondria. This is quickly 
followed by ribosomes and rough vesicles. By 8 h af~er 
entry, all vacuoles are studded with ribosomes (157). 
Evidence suggests that the bacteria avoid the 
bacteriocidal effects of intracellular enzymes by 
preventing fusion of the phagosome with the enzyme-
carrying lysosomes (156) . 
The fact that bacteria are inside the phagocytes 
probably protects them from the bacterocidal effects of 
human serum in vivo. They have been shown to be 
susceptible in vitro (3, 31, 243). Interestingly, while 
coating with specific antibody and complement increases 
uptake, it does not significantly affect the ability of 
b_,_ p neumophila to multiply intracellularly (159, 182, 
3 13, 339). Humoral immunity is thus not the major means 
b y which the organism is cleared . 
Several studies have shown that activated 
macrophages are able to inhibit bacterial multiplication 
( 160 , 222, 339) . These studies used the supernatents 
f rom mitogen-stimulated cells to activate the 
pha gocytes. Bhardwaj et al. (23) have shown that human 
r ecombinant Y -interferon at relatively high 
concentrations will also inhibit multiplication . They 
al s o noted that the phagosome in the activated cell was 
structurally similar to that observed in the 
nona c tivated phagocyte. Most studies have demonstrated 
litt le effect on the ability of the cell to kill the 
organism. A study using athymic nude mice (83) suggests 
that cell-mediated immunity is important in host defense 
in v i v o as well . 
PMNs do not support the intracellular growth o f 1...:_ 
pneumophila but neither do they kill the bacteria 
efficiently (157, 158) . Lochner and co-workers (124, 
195) h av e shown that a toxin produced by the organism 
lead s to impaired activation of the superoxi d e-
g e nerating c omplex which may explain the reduced k i ll i ng 
ability, since both virulent and av irulent strains are 
sens i tive to the effects of oxygen metabolites generated 
in vitro. 
The role of erythr omycin and rifampin in therapy 
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seems to be to inhibit multiplication rather than to 
kill. These antibiotics are able to penetrate the cell, 
but intracellular bacteria appear to be protected. 
Extracellular organisms are killed at antibiotic levels 
near the minimal inhibitory concentrations, but 
intracellular organisms are resistant to killing at 
higher concentrations equal t o or greater than peak 
serum levels in humans . Failure to treat for an 
adequate length of time may lead to relapses as once the 
antibiotic was removed the bacteria began to multiply 
again ( 156) . 
Transmission 
The large number of b ranched-chain fatty <.~ c ids 
found in J,egi'2_nella species are comr:ion in thermophilic 
bacteria (118). This association led Fliermans and 
colleagues to look for legionellae in a variety of 
aquatic habitats. Theirs was the first report of 
nonepidemic-related isolation o f .l ·. i:~neuzn_ophi).a in 
natural lakes in the Southeast (120). This study was 
expanded and they subsequently found legionell;:ie to be a 
common inhabitant of freshwater lakes and rivers over a 
wider geographic area (119). The organism also was 
isolated from a thermally altered lake . They found it 
to be able to survive extreme ranges of environmental 
conditions ( i. e., isolated from wa t ers ranging in 
t~mperature from 5.7 to 63C and pH from 5.5 to 8.1). It 
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also has been detected in mud (213), rainwater (308)~ 
and in oxidation ponds and fish ponds (17). In most 
instances, even in those specimens with the highest 
numbers, 1_,_ pneumophila comprised less than 1% of the 
total bacterial population (119) Legionella-like 
organisms have been observed in the Caribbean Ocean but 
in areas tested in the United States neither isolates 
nor DFA positive samples were obtained once salinity 
levels increased to saltwater conc entrations (118). 
Skal iy and McEachern (273) showed that 4 strains of 1_,_ 
pneumophila were able to surv i v e 69 - 139 days in 
dist illed water and 364-369 days in tap water in seeded 
samp l es . 
Once legionellae were known to survive and mult i ply 
in water, the question of amplifie r s and disseminators 
arose. Early outbreaks were associated with cooling 
towers and e v aporativ e condensers ( 70, 79 , 138, 183, 
213). These heat rejection s ystems were suspected to be 
important in dissemination of disease. This mechani sm 
could not a c count for all outbreaks (e.g . , St. 
Elizabeth ' s Hospital used the "open wind ow" air 
condi ti oning system [ 290]) no r f or a l l c ases in s ome 
(2 15) . Airborne spread as a resul t of soil excav a tions 
was postu lated to be the cause in the St. Elizabeth ' s 
outbreak. 
Reports of isolation of legionellae from potable 
water and its association with LD then began to appear 
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(12, 34, 115, 146, 270, 281, 310, 343). As Muder, Yu, 
and Woo point out in their review (215), virtually all 
outbreaks occurring after this time cite the water 
distribution system as a culprit, usually with no 
stronger evidence than earlier studies incriminating 
heat rejection systems . 
Airborne transmission with inhalation of 
contaminated aerosols is undoubtedly an important means 
of infection; however, other ways may be possible. 
Human pneumonias may develop following aspiration, 
usually of organisms in the oropharynx (215). The 
generally low attack rates associated with LD as well as 
the high incidence of nosocomial LD in patients with 
conditions predisposing to subclinical aspiration (e . g. 
general anesthesia with endotracheal intubation) might 
support this theory. A weakness is the lack of evidence 
that _k:_ pneumophila colonizes the oropharynx. Bridge 
and Edelstein (42) found only 3 of 186 (l.6%) throat 
spec imens positive by DFA using CDC ' s criterion, and no 
organisms were isolated . Their study group included 40 
patients housed in a building which had been associated 
with endemic LD; the conditions of the patients were not 
desc ribed. Aspiration of contaminated drinking water is 
possible . _k:_ pneumophila has been isolated from ice 
machines which may be the primary source of a patient ' s 
drinking water (215). 
Ingestion as a means of infection has received less 
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attention. This is interesting, as the only parameter 
that could be statistically linked to acquisition of 
disease in the 1976 outbreak was ingestion of water 
(121). Katz and Matus (175) have shown that guinea pigs 
develop amild pneumonitis and fever when given infected 
water to drink. A study by Jones et al. in Connecticut 
(170) f9und a significant association of nosocomial 
disease with antacids. The role of antacids is unclear 
but they postulate that this neutralizes gastic pH, thus 
facilitating infection by ingestion, possibly followed 
by aspiration and pneumonia. 
Heat Rejection Systems 
Cooling towers and evaporative condensers are 
widely used to dissipate unwanted heat into the 
atmosphere. All depend on contact between circulating 
water and ambient air. As the heated water is passec 
through an airstream, evaporation occurs and the 
remaining water is cooled. This cooled water collects 
at the bottom of the unit and is discharged 
intentionally at intervals to control the build-up of 
sediment. This water may be "bled" into a storm sewer, 
sanitary sewer, or even a nearby stream or lake. In 
addition, the airstream leaving the unit is saturated 
and may contain a small portion of the circulating water 
in the form of droplets known as drift . Airborne 
contaminants near the unit may be absorbed and organisms 
in the circulating water may be released into the 
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environment (212). 
The air conditioning system was implicated in the 
1968 outbreak of Pontiac fever (176). Sentinel guinea 
p igs exposed to the incriminated building developed 
disease. Laboratory studies using whole body aerosol 
exposure to evaporative condenser water collected at the 
site also led to disease in the guinea pigs. L. 
pneumophila was isolated from cooling tower water during 
an outbreak of LD in Memphis, Tennessee (79). This 
tower was thought to be a source for the outbreak but 
from evidence gathered at the time, other reservoirs 
were probable and the possibility of diagnostic bias in 
identifying cases of LD could not be excluded. Stronger 
evidence implicating an evaporative condenser at a 
Geo rgia country club was reported by CDC researchers 
investigating an outbreak of LD ( 70) . 1..:_ pneumophi l~ 
serogroup 1 was isolat ed only from condenser water and 
tracer studies suggest ed that exhaust was d i rected 
toward certain tees on the golf course. The degree o f 
gol f i ng activity during the likely exposu re period was a 
ri sk factor for illness. 
A more recent s tudy in Rhode I sland ( 127 ) al s o 
incriminates cooling towers as a source. 1_,_ pneumophil a 
was isolated from potable water but the decline in c ases 
of LD following treatment of only t h e c oo l ing towers led 
the investigators to conclude that this was the primary 
d isseminator. The follow-up period was brief (10 
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months) and did not include the months when most cases 
initially occurred. This conclusion may be premature 
given the seasonality of LD and the possibility of less 
dili gent searches for LD after treatment of the towers. 
Potable Water 
Tobin and colleagues were the first to report the 
isolation of 1..,_ pneumophila from potable water taken 
from a shower unit in the area in which patients with LD 
were housed (11). Since that time, hospital potable 
water has been found to contain 1..,_ pneumophila in many 
sites within an institution as well as in institutions 
all over the world (12, 34, 72, 115, 146, 209, 270, 281, 
310 , 316, 343). These isolates hav e been associated 
with nosocomial LD outbreaks in some instances (12, 34, 
115 , 146, 270, 281 , 310, 343), but not in others (72, 
77, 120, 316). An interesti ng case is the epidemic a t 
Wadswort h Veterans· Administration Hospital . Originally 
thought to be the result of contaminated cooling towers, 
the number of cases declined dramatically only after the 
potable water supply was treated. No isolates of 1..,_ 
pneumophila and no cases of LD hav e been found in over 2 
years after treatment (27 0 ). Th e fact that many LD 
patients do no t shower in the hospi t al nor c ome into 
contact with aerosols generated by hot water faucets 
suggests other methods of exposure. Cases of LD hav e 
b een reported when various aeroso l-producing dev ices are 
fi lled or rinsed with tap water , including a mechanical 
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humidifier (171) a portable room humidifier and jet 
nebulizers used in respiratory therapy (6). 
Non-hospital associated epidemics in which potable 
water has been suggested also have been seen (11, 12, 
33 5) . Legionellae have been isolated in residential 
potable water without apparent associated illness (7, 
64 ). Organisms have not been isolated from treated 
water entering the distribution network (64, 304), 
al though in one case (304) low numbers were seen using 
DFA . This would suggest that public water supplies are 
no t the source or at most would seed only small numbers 
into the distribution system . 
Conditions in hot water sources may be conducive to 
survival and multiplication. Water temperatures lower 
than 60 C have been associated with isolates (7, 244, 
340 ) as well as stagnation which occurs during periods 
whe n tanks are not in use (61, 115). Faucet 
obstruc tions (e.g. aerators, backflow preventors) have 
been shown to support the surv i v al of 1._,_ pneumophila 
(61 ). Another material implicated in increasing t h e 
abi l i ty of the organism t o survi v e is the rubber washer 
(11 5 , 267). A study by Niedenv eld and as s ociates (2 2 5) 
found 9 of 14 rubber compou nd s and 15 of 30 constituents 
would support the growth o f L. pneumophila in naturally 
contaminated hot water . 
Other bacteria may provide nutrients for the 
l egionellae . Stout et al. (282) found that the presence 
40 
of environmental bacteria enhanced the survival of 1-.,_ 
pneumophila. Schofield and Loeci (266) showed that in 
the absence of other organisms, 1-.,_ pneumophila failed to 
colonize various washer fittings in laboratory 
experiments. Both groups suggest that sediments and 
stagnant warm water allow increased multiplication of 
other flora which may in turn provide nutrients for the 
growth or survival of legionellae. 
Role of Protozoa and Algae 
In addition to the bacteria found in association 
with legionellae, there is evidence to suggest 
interactions with other organisms occur, which are 
favorable to the legionellae. Tison et al. (303) 
reported in 1980 that 1-.,_ pneumophila would grow in 
association with the blue-green algae (cyanobacteria). 
They isolated 1-.,_ pneumophila from a thermophilic algal 
mat community growing at 45C in a man-made thermal 
effluent. Their experiments suggested that the 1-.,_ 
pneumophila were using algal extracellular products as 
carbon and energy sources and that growth was dependent 
on active photosynthesis . They theorized that this may 
be a mutualistic association, with the algae providing 
oxygen for the bacteria while the algae used the carbon 
dioxide produced by the bacteria for photosynthesis. 
Since then, species of green algae (chlorophyta) have 
also been shown to enhance growth of 1-.,_ pneumophila 
(162). Since algae are common contaminants in aerosol-
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generating water systems it is possible that inhalation 
of a single algal cell carrying b_,_ pneumophila would be 
an infective dose. 
In the same year (1980), T J. Rowbotham reported 
that b_,_ pneumophila was pathogenic for free-living, 
ubiquitious freshwater and soil amoebae of the genera 
Acanthamoeba and Naegleria (258) He suggested that a 
fecal vacuole or amoeba full of legionellae could be the 
infective particle for humans. Other researchers have 
confirmed this preliminary work with a variety of 
amoebal species (1, 224, 309). Fields and associates 
(113) have demonstrated a similar relationship with the 
ciliated protozoan Tetrahymena pyriformis . 
There appears to be a limited range of infectivity, 
with some species of amoebae supporting growth of only 
certain strains of certain serogroups of b_,_ pneumophila 
(258). The legionellae have been shown to grow 
intracellularly and viable amoebae are required (1, 113, 
155, 224). Newsome et al. (224) have shown that the 
intracellular vacuoles produced in the amoebae are 
similar to those seen in human macrophages There is an 
alignment of mitochondria and ribosome-like structures 
along the vacuole membrane . 
Barbaree and co-workers (10) were the first to look 
for protozoa as well as legionellae in investigating an 
outbreak of legionellosis They found amoebae as well 
as two species of ciliates in cooling tower water 
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containing .k,_ pneumophila. Two of the 4 cooling towers 
investigated were implicated in the spread of disease 
and both had amoebae and/or a ciliate as well as the L. 
pneumophila. One tower which was not implicated had 
bacteria and amoebae; the other tower had only 
legionellae. They suggested that the protozoa may be 
reservoirs for supporting survival and multiplication of 
virulent legionellae. Rowbotham (259) suggests that .k,_ 
pneumophila may be protected from biocides used in 
various water treatment programs by infecting amoebae 
which then encyst. The resulting cysts are resistant, 
especially to the chlorine commonly used in the water 
supply industry. A study by Tyndall and Dominque (309), 
using only one strain of .k,_ pneumophila isolated from 
the environment, suggests that neither the infected 
amoebae nor the .k,_ pneumophila has increased virulence 
or pathogenic potential as a result of their 
relationship. This may not be true for other strains of 
bacteria or for interactions with other species of 
protozoa. 
In addition to their roles as reservoirs and 
amplifers, amoebae have been postulated to play a role 
in human disease. Rowbotham (260) suggests that Pontiac 
fever is a result of hypersensitivity pneumonitis to the 
vesicles of acanthamoebae coupled with a mild infection 
by .k,_ pneumophila. When the vesicles and intact 
Legionella-containing amoebae are inhaled by someone 
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with increased risk, LD results. Dual infection, which 
has been reported rarely, also could be explained on 
thi s basis as well, since a single amoeba has been shown 
to be infected by more than one type of 
Legionella (260). Since the intracellular changes in 
amo ebae and human leukocytes are similar, it is likely 
tha t humans are only incidental hosts for the 
legionellae, whose natural habitat is the aquatic 
envi ronment. As pointed out by Spriggs (278), "It ' s 
humbling to consider that Legionella ' s shift from 
amoebae to humans is less a leap than a lateral 
shuffle." 
The possibility of other animal reserv o i rs has 
receiv ed little attention . Serological studies have 
shown that a surprisingly high number of horses (31 . 4% 
in one study [67]) hav e elevated titers to b_,_ 
pneumophila when va l ues f ound in humans are used to 
dete r mine infection. Direct challenge has not resulted 
in di sease, but seroconv ersions were noted (65). 
Various species o f primates as well as small numbers of 
cattl e , swine, sheep, antelope, water buffalo , and dogs 
have h ad elev ated ti t ers (53, 65, 67). Aqua t ic birds 
have b een shown t o hav e t i ters whi ch paralleled those 
seen in the normal human population, and a few birds 
(e .g . pelicans) had v alues much hi gher, suggesting an 
unusual prevalence in their environment or a unique 
susceptibil i ty to infection (65) The possibility o f 
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cross-reactions, discussed previously, in the 
sero logical studies cannot be eliminated. Only one 
study has reported attempts to isolate legionellae from 
animals. Cohen et al. (63) reported that 17% of 139 
bovine cadaver lungs and lungs from 4% of 29 slaughtered 
calves were positive by DFA; however, only 2 strains of 
1-,_ pneumophila serogroup 1 were isolated from 2 
cadavers . 
Objectives of the Study 
1. To evaluate a buffered egg yolk medium for its 
ability to support the growth and maintain 
virulence of 1-,_ pneumophila. 
2 . To confirm the ability of pol ymixin B to alter 
morphology and virulence of another strain of 
1-,_ pneumophila . 
3. To compare virulent and avirulent 1-,_ 
pneumophila for differences i n morphology, 
plasmid cont ent, proteins as detected by 
sodium dodecylsulfate-po l yacrylamide gel 
electrophoresis, and r eacti v ity with 
monoclonal and polyc l onal anti b od ie s . 
4. To evaluate three species o f fish b o th as a 
model for infecti on and as a po tential 
environmental reservoir f o r 1-,_ pneumophila. 
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MATERIALS AND METHODS 
organisms and Media 
Virulent and avirulent Legionella pneumophila, 
serogroup 1, were kindly provided by Dr. Washington C. 
Winn, Jr. (Department of Pathology, University of 
Vermont, College of Medicine, Burlington, VT 05405). 
This strain, Burlington 1, originally was isolated from 
a patient with Legionnaires ' Disease. The original 
isolate was propagated on modified Mueller-Hinton agar 
to produce the avirulent form. 
Virulence was confirmed by inoculating guinea pigs 
with growth from a 72 h culture of each organism as 
described below. Aliquots of the liver and spleen 
suspensions (see virulence studies) from infected 
animals were frozen at -70C for future use. In 
addition, organisms isolated from these tissues as well 
as those from the original culture were used to make 
heavy suspensions in 1 ml aliquots of freezer broth (50% 
glycerol, 50% trypticase soy broth) and frozen at -70C. 
For each experiment requiring bacteria, an aliquot of 
either tissue or culture suspension was thawed, plated 
on buffered charcoal yeast extract agar and incubated at 
35C in an atmosphere of 5% co2 for 72 h. 
Buffered charcoal yeast extract agar containing a -
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ke toglutarate (BCYE) prepared as shown in Appendix A 
was routinely used to culture the organism. When 
material suspected of contamination was cultured, it was 
ne cessary to use a semi-selective medium (BMPA a ), 
prepared as shown in Appendix A. Also in this Appendix 
are the formulas for the test medium, egg yolk buffered 
agar (EYB), and yeast extract buffered broth (YEBB) 
Animals 
Male Hartley strain guinea pigs weighing 250 to 
300 g were housed individually in plastic cages and 
a l lowed free access to standard guinea pig food and 
water. During and after inoculation the ANimals were 
handled and housed within a biologic safety cabinet . 
Hogchoker (Trinecte maculatus) 7-12 cm in length 
(see Figure 1) were captured by trawl net from the Ware 
and Nansemond Rivers on sev eral occasions. Salinities 
and water temperature were roughly equ i v alent in the two 
river s ystems. Fish for the chemotactic study were hel d 
in tanks of flowing seawater at ambient temperature 
until use and fed Zeigler ' s trout chow d aily. Fi s h f o r 
the v irulence studies were h oused at r oom temperature i n 
ten gallon aquaria (approxi matey 20 f i s h per t ank ) 
containing Instant Ocea~ (Aquarium Sys t ems, Mentor , 
Ohio 44060) prepared so t h at the spec ific gravity fe ll 
between 1.020 and 1.023 . Approximately 30% of the water 
i n each aquarium was replaced with fresh Instant Ocean 
every other day. Fish wer e fed frozen brine shrimp 
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Figure 1 
Ware or Nasemond River Hogchoker (Trinecte maculatus) 
/ 
every other day. The aqua·ria were kept in a biological 
s afe ty hood during all experiments . 
Spot (Leiostomus xanthurus) 9-13 cm in length (see 
Figure 2) were captured and handled as described above 
f or the hogchoker. 
Golder shiner minnows (Notemigonus crysoleucas) 7-
13 cm in length (see Figure 3) were purchased from 
Paul' s Bait Shop, 3400 Mechanicsville Turnpike, 
Richmon.ct, Virginia 23223. These fish were housed at 
r oom temperature in ten gallon aquaria (approximately 20 
f i sh per tank) containing tap water treated with Start 
Ri ght'~ · (Jungle Laboratories Corporation, Cibolo, Texas 
78108). Approximately 30% of the water in each aquarium 
was replaced with fresh treated tap water every other 
day . Fish were fed frozen brine shrimp daily. The 
aquaria were kept in a biological safety hood during a l l 
experiments. 
Vi rulence Studies 
A. Guinea ~ 
1. Determinati on o f v iru lence 
Organisms initially were evaluated t o c onfi r m 
v irulenc e o r a v irulence. Cu l tures of eac h iso late g r own 
on BCYE f o r 72 h at 3 7C in a 5% co 2 atmo sphere were 
suspended in 9 ml of YEBB a nd adjusted to match 
approximately the opacity of a McFarland No. 3 standard. 
Serial 100-fold dilutions were made in YEBB; 0 . 1 ml 
aliqu ots of each dilution were plated in duplicate on 
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Figure 2 
Ware or Nansemond River Spot (1eiostomus xanthurus) 
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Figure 3 
Golden Shiner Minnow (Notem:j,_gonus crysoleucas) 
BCYE; streaked, and incubated to determine the colony 
count. One ml aliquots of the original suspension were 
injected intraperitoneally into the guinea pigs. 
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Animals were observed daily for signs of infection for 7 
days. Moribund animals were killed with an overdose of 
co 2 gas and livers and spleens removed asceptically. 
Portions of these tissues were emulsified in saline and 
cultured on BCYE and EYB The remaining suspensions and 
tissues were aliquoted and frozen at -70C. Animals 
which remained healthy for 7 days were sacrificed as 
above. 
2. Media evaluation 
EYB and BCYE were tested for their ability to 
maintain virulence. Organisms isolated from spleen or 
liver suspensions of moribund animals were transferred 
every 7 days to the same type of medium (BCYE or EYB) 
and incubated in a 5% co 2 atmosphere. Animals were 
inoculated as described above using organisms grown for 
72 h at the following interv als: after 15, 20, 25, and 
26 transfers. The 25th passage also was tested by 
injecting 1 ml of a 10-fold dilution of the original 
suspension of organisms grown on BCYE or EYB. 
3. Polymixin B studies 
Polymixin B (Pfizer, Inc . , New York, New York 
10017) was added to bacterial suspensions to evaluate 
its effect on the virulence of the organisms. One ml of 
a 10 X solution of polymixin B was added to 9 ml of 
bacteria suspended in YEBB to yield a final antibiotic 
concentration of 160 µg/ml. One ml of saline was added 
to another suspension to serve as a control. All 
suspensions were incubated at 37C in a 5% co 2 atmosphere 
for 5 h. Following the incubation period, aliquots were 
removed for colony counts and one ml was injected 
intraperitoneally into each guinea pig. Two guinea pigs 
were inoculated per suspension Bacterial suspensions 
were prepared from organisms grown on BCYE for 72 h as 
desc ribed above . The avirulent organism was tested 
using only the initial suspension with a turbidity 
approximating that of the McFarland No. 3 standard. The 
virulent strain was tested using the initial suspension 
and ten-fold and one-hundred-fold dilutions of this 
preparation treated with both. 
B. Fish 
1 . Hogchoker 
This species of fish was chosen for the 
prel iminary studies because it was thought to be the 
hardi est of the three and was available in larger 
numbers than the spot. It was necessary to establish 
guidelines for inoculum size and vo lume since little 
rel e v ant data were found. Initially, bacterial 
suspensions were prepared as described for the guinea 
pig studies, substituting sterile teleost saline (0.7% 
NaCl) for the YEBB. This number of organisms (0.3 ml 
injected) had no effect on the fish, so subsequent 
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expe riments used bacterial suspensions prepared as 
fol lows: each strain (virulent and avirulent) was 
streaked for confluent growth on one BCYE plate and 
incubated at 35C in a 5% co 2 atmosphere for 72 h. The 
organisms from each of these plates were suspended in 10 
ml of sterile 0.7% NaCl. Aliquots of these suspensions 
were removed for injection and further dilution for 
either injection or colony counts . 
Each fish received up to 0.5 ml of a bacterial 
suspension inoculated intraperitoneally using a 25 
gau ge, 5/ 8 inch needle (Becton-Dickinson, Rutherford, 
New Jersey 07070) for each. Fish were marked by 
removing a p o rtion of one fin p r i or to injection. 
Uninoculated, u nmarked fish were added to the 
aquaria to serve as controls . Tanks were checked at 
least twice daily and any dead fish removed. The 
per i t oneal cavity of each dead fi s h was entered 
ascept i cally and cultured on BMPA a medium. Su r v i v ing 
fish in some experiments were k i lled by severing the 
spinal cord adjacent to t h e skul l and t he p er i toneal 
cavity cultured as abov e . 
Aquaria i n s ome e xperiments were tested f o r 
the presence of Legionel l a b y cultu ring al iquots o f the 
water on BMPA & medium 24 h afte r injecting the fish 
and by culturing the charcoal filter at the end of the 
experiment. All cultures were incubated a minimum of 10 
d ays before being discarded. 
Isolates with colonial morphology typical of L. 
£!leumophila were stained using Gram's method and 
subcu ltured to a sheep blood agar plate and a BCYE 
plate . Isolates with typical gram reaction and 
mo rphology which grew on the BCYE but not the blood agar 
pl ate after 7 days were presumptively identified as 1_,_ 
pneumophila. Questionable isolates were tested using a 
direct fluorescent antibody reaction (Litton Bionetics, 
Inc . , Charleston, South Carolina 29405). 
2. Spot 
Virulence was determined for this species as 
described for the hogchoker. Early studies suggested 
that the spot were more susceptible than the hogchoker. 
To test this hypothesis, spot and hogchoker were 
injected intraperitoneally with 0 5 ml each of the same 
suspension of either virulent or avirulent L. 
pneumophila prepared as described above. The fish were 
housed in the same tank with uninoculated fish of each 
spec ies added to serve as controls. 
In another experiment, smears of the peritoneal 
cavity of each spot were made, stained with Wright's 
stain and then stained with Giemsa stain. These smears 
were examined for the presence of various cell types. 
This species was also used to evaluate the effects 
of continuous transfer of the virulent 1_,_ pneumophila on 
artificial media. Suspensions of virulent 1_,_ 
penumophila transferred twice and 27 times on BCYE were 
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prepared as described above in teleost saline. Fish 
r eceived either 0.5 ml or 0.4 ml of these suspensions 
via intraperitoneal inoculation. 
3. Minnows 
Since 1_,_ pneumophila is known to survive in 
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fresh water for prolonged periods of time, an experiment 
was done to determine the effects of adding known 
numbers of organisms to water similar to that to be used 
to house the fish. Ninety-nine ml of tap water was 
inoculated with one ml of a suspension containing either 
a 3.6 x 104 virulent or 4 7 x 104 avirulent organisms. 
These bottles were incubated at room temperature with 
the tops kept loose in a biologic safety cabinet. 
Aliquots were removed daily for 7 days and plated or 
diluted and plated onto BMPA a agar. These plates were 
incubated and examined for the presence of L. 
pneumophila In addition, water in the aquaria was 
cultured daily for the presence of L. pneumophila by 
plating 0.01 ml in duplicate on BMPAa medium. The 
charcoal filter was also cultured at the end of each 
experiment, using BMPAa medium. 
Virulence of 1_,_ pneumophila for this species 
was determined as described for the hogchoker. 
Chemotactic Assays 
A. Human 
Fourteen ml of heparinized blood was collected from 
each of 4 volunteers. Mononuclear c ells were isolated 
using a ficoll-hypaque gradient (LSM solution, Litton 
Bionetics, Inc.). The cells were washed 3 times in 
Eagle Minimum Essential medium (Hazleton Research 
Products, Inc., Denver, Pennsylvania 17517) containing 
10% fetal calf serum (Eagle MEM) . Viability and cell 
concentration were determined by trypan blue exclusion 
and the cells suspended to a concentration of 6 x 10 6 
vi ab le cells/ ml in Eagle MEM. 
Bacterial suspensions were prepared using virulent 
and avirulent 1._,_ pneumophila grown on BCYE for 72 h at 
35C in a 5% co 2 atmosphere as well as ~ coli cultured 
on s heep blood agar for 24 h using the same incubation 
conditions. Each organism was suspended in 9 ml of 
sali ne and adjusted to match approximately the opacity 
of a McFarland No. 3 standard. Colony counts were done 
and the suspensions centrifuged for 20 min at 3,000 rpm 
(2, 000 x g) using a Sorvall RC-3 automatic refrigerated 
cent r ifuge with an HG-4L he ad (DuPont Instruments, 
Wi l mington, Delaware 19898) to sediment the cells. 
Cells were killed by resuspending them in a 10% 
fo rmalin-saline solution. Prior t o use in the 
chemotactic assay, organisms were washed once and 
r esu spended in Eagle MEM to a concentration of 5 x 10 8 
cells/ ml. 
The assay was carried out using a Boyden chambe r 
(3 5) and testing each organism as well as a negative 
control in duplicate . The b ottom well o f the chamber 
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(Ahlc o Corporation, Meriden, Connecticut) contained 0.2 
ml of the bacterial suspension of medium alone. A 5.0 
um membrane filter (Wallabs, Fairfax, California 94930) 
was placed over this well, the upper chamber attached, 
and 0.2 ml of the mononuclear cell suspension added. 
Chambers were incubated at 37C in a 10% co2 atmosphere 
for 90 min. After incubation, the filters were removed 
and stained with Wright's stain. Dried filters were 
coverslipped and examined using 45X magnification. 
Mononuclear cells were differentially counted on the 
upper and lower surfaces of the filter. 
Results were expressed as a chemotactic index, or 
the ratio of cells on the lower surface of the filter to 
the total number of cells counted (500) . Chemotactic 
act i v ity was considered to be positive when the number 
of c ells migrating through the filter equaled or 
exceeded 2.5 times the negati v e control . 
B. Guinea pig 
Peritoneal macrophages were collected using a 
mod i fication of the technique described by Rocklin 
(2 49) . Briefly, 10 ml of light mineral oil was injected 
intraperitoneally into male Hartley strain guinea pigs 
about 72 h prior to performing the chemotactic ass a y. 
Animals were anesthet i zed with ether prior to injection . 
Animals were sacrificed using an overdose of ether. A 6 
to 7 cm skin incision down to the peritoneum was made 
and 50 ml of cold Eagle MEM injected intraperitoneally . 
A lS gauge needle attached to a plasma transfer set 
(Fenwal Laboratories, Division of Travenol Laboratories, 
Inc , Deerfield, Illinois 6001S) was inserted into the 
abdomen. The oil and wash solution was collected via 
this tubing into sterile plastic SO ml conical 
centrifuge tubes. Tubes were centrifuged for lS min at 
SC and lSOO rpm in the Sorvall RC-3 centrifuge. Oil and 
supernatent were removed and the cells transferred to 
sterile 12 ml centrifuge tubes and washed twice more (S 
min at SC and 1000 rpm) in Eagle MEM. Cell viability 
and concentration were determined by trypan blue 
exclusion and the cells suspended to a concentration of 
S x 10 6 viable cells/ ml in Eagle MEM. 
Chemotactic assays were performed using guinea pig 
peritoneal macrophages as described for the human 
mononuc lear cells abov e. 
C. Fish 
Kidney macrophages were isolated from all three 
species using the same technique. Fish were killed by 
severing the spinal cord adjacent to the skull with a 
scalpel. Kidneys were asceptically removed, washed in 
teleost buffered saline and transferred t o Minimal 
Essenti al Medium (MEM) (Gibco Diagnostics, Lawrence, 
Massachusetts 01843) containing 10% fetal calf serum. 
Kidney tissue was homogenized and clumps of cells 
allowed to settle in a 10 ml plastic test tube. 
Macrophages were separated fr om the cell suspension 
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using the Percoll density gradient technique of Braun-
Nesje et al. (37) as modified by Weeks and Warinner 
(320). The macrophage fractions were removed from 
gradi ents and washed once in teleost buffered saline. 
Trypan blue exclusion was used to determine viability 
and cell concentration. Cells were suspended to a 
concentration of 5 x 10 5 viable cells/ml in MEM. 
Chemotactic activity was quantified by a 
modi fication of the Boyden technique (320) using a 
doub le chamber apparatus (Nucleopore Corporation, 
Bethesda, Maryland). The lower chamber contained 0.2 ml 
formalin killed 1._,_ pneumophila (virulent or avirulent) 
or ~ coli prepared as in the human chemotactic assay 
technique except that the cells were washed and 
resuspended in teleost buffered saline with 10% v/v 
human serum. Medium alone was added to three chambers 
to serve as a negative control. The upper chamber of 
each contained 0 . 2 ml of the macrophage suspension. 
Chambers were separated by a 8.0 µm membrane filter 
(Mi llipore SSWPO 1,300 membrane). Chambers were 
incubated in triplicate at lSC, membranes removed at 30, 
60, and 90 min intervals, fixed with methanol, and 
stained with Wright's stain. Macrophages were 
differentially counted on the upper and lower surfaces 
of the filter. Results were expressed as a chemotactic 
index, or the ratio of macrophages on the lower surface 
of the filter to the total number of cells counted (at 
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l eas t 100). 
p lasmid Analysis 
Virulent and avirulent L. pneumophila were analyzed 
for the presence of plasmids using the procedure 
described below. A loopful or organisms grown on BCYE 
for 72 h as previously outlined was suspended in 100 µl 
of Schlae ' s TE buffer (see Appendix B) and mixed 
vigorously using a vortex mixer . Next, 200 µl lysing 
buffer (see Appendix B) was added and mixed gently by 
inversion 12 times. Following a 20 min incubation at 
room temperature , 600 µl of phenol·chloroform, 1:1 
(v/ v ), was added and this solution inverted gently. 
Samp l es were centrifuged 6 min at 15,600 x gin an 
Eppendorf Micro Centrifuge Model 5414 (Brinkmann 
Instruments Company, Westbury, New York 11590). The 
aque ous supernatent (lysate) was aspirated and 20 pl of 
lysa t e added to 5 µl of sample buffer (see Appendix B). 
This lysate-sample buffer mi xture ( 20 pl) was 
app lied to a well made in a 0 . 6% agaro se gel. This gel 
was placed in a horizontal gel electropho resis apparatus 
(Bethesda Research Laborato ries, Ga ithersburg , Ma r yland 
20877 ) c ontaining l X E buffe r (see App e ndix B) , p owe r 
turned t o 100 v olts f o r 5 mi n and t hen to 50 vo lts un t il 
the blue tracking dye reached the edge of the gel 
(2 -3 h) . Power was turned off and the gel stained with 
ethidium bromide (50 pl of a 1 mg/ ml ethidium bromide 
so lution added to 50 ml of tap water in a metal pan) for 
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30 min followed by destaining for 30 min in tap water. 
Gels were analyzed using long wave ultraviolet light and 
photographed with a Polaroid camera. 
Electron Microscopy 
Virulent and avirulent 1_:_ pneumophila were grown on 
BCYE for 72 h at 37C in a 5% co2 atmosphere. Bacteria 
were suspended in 9 ml of YEBB and adjusted to match 
approximately the opacity of a No. 3 McFarland standard. 
One ml of a lOX solution of polymixin B was added to one 
suspension of virulent organisms to yield a final 
concentration of 160 pg/ ml. One ml of 0.85% NaCl was 
added to another suspension to serve as a negative 
control. The avirulent organisms were treated 
similarly. All suspensions were incubated for 5 h at 
37C in a 5% co2 atmosphere. Following this incubation, 
2 ml of 2.5% (v/ v) glutaraldehyde was added to each tube 
and the tubes incubated at 4C overnight. The bacterial 
cells were then centrifuged for 10 min and washed 3 
times (10 min each) with sodium cacodylate buffer (pH 
7 .2) containing 3mM CaC1 2 . The cells were post-fixed 
with 2% osmium tetraoxide (Os04 ) for 2 h The cells 
were washed once in sodium cacodylate buffer as abov e 
and then embedded in 2% Noble agar following post-
fixation. These blocks were dehydrated in a graded 
alcohol series and then placed in propylene oxide. The 
blocks were left overnight in a solution of 50% 
propylene oxide and 50% Epon 812. This propylene 
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oxide/ Epon mixture was replaced by 100% Epon the next 
morn i n g for 3 h. The blocks were then embedded in 
plasti c capsules filled with fresh Epon and incubated at 
60C fo r 3 days. The Epon blocks were cut using an 
ultramicrotome equipped with a diamond knife . Sections 
with g ray transluscence were picked up on a 200 mesh 
copper grid and stained for 30 sec using saturated 
aqueou s uranyl acetate followed by lead citrate for 1 
min . The ultrathin sections were examined at 20 KV in a 
Phi lips EM 400 electron microscope . 
Other bacterial suspensions were analyzed for the 
presence of capsules using ruthenium red . Cells were 
prepared as described above with the exception of the 
post-fixation step. The 2% Oso4 solution was modif i ed 
by the addition of 1 5 mg ruthenium red per ml of Oso4 . 
The r est of the procedure remained the same . 
Sodium Dodecylsulfate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
The procedure used was a modification of the 
technique of Laemmli (191) ; all reagents and chemicals 
were supplied by Bio-Rad Laboratories (Roc kv i l le Center , 
Ne w Yo r k 11571) un l ess otherwis e noted . 
A. Specimen preparati on 
Each bacterial strain was streaked f o r confluent 
growth o n 3 BYCE plates (1 plate f o r the gradient gel) 
and incubated for 72 h at 37C in a 5% C0 2 atmosphere. 
All vis ible growth was collected and suspended in 10 ml 
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of sterile ~aline using cotton-tipped swabs. Cells were 
sedimented by centrifugation for 15 min at 23 C at 3,000 
rpm using the Sorvall RC-3 centrifuge. The pellet was 
resuspended in 5 ml of a solution of phenol, glacial 
acetic acid, and water in a ratio of 2:1:0.5. The 
pellet was vigorously mixed by using a vortex mixer for 
2 min and this mixture incubated at 37C for 1 h. 
Following this incubation, the mixture was 
centrifuged for 10 min at 10,000 rpm (15,000 x g) at 4C 
using a Sorvall RC-SB refrigerated superspeed centrifuge 
equipped with a SA 600 head (DuPont Instruments, 
Wilmington, Delaware 19898). The supernatent was 
collected into a 13 x 100 mm test tube and the soluble 
proteins precipitated by the addition of cold acetone to 
fill the tube. The tube was incubated at 4C a minimum 
of 15 min and the proteins pelleted by centrifuginq at 
3,000 rpm for 15 min. The residual phenol and acetic 
acid were removed by washing the pellet with l ml colc 
acetone 3 times. The pellet was then allowed to dry. 
The pellet was suspended in 300 µl (400 µl for the 
gradient gel) of sample buffer (see Appendix B) and the 
proteins disrupted using a pasteur pipette. This 
mixture was transferred to a 400 µl polyethylene micro-
centrifuge tube The molecular weight standard was 
prepared by adding 10 µl of the standard to 190 91 of 
the sample buffer in a microcentrifuge tube. This 
standard was composed of the following: lysozyme 
(14,400 daltons) soybean trypsin inhibitor (21,500), 
carbonic anhydrase (31,000), ovalbumin (45,000), bovine 
serum albumin (66,200) and phosphorylase B (92,500). 
All samples were heated in a boiling water bath for 
S min and then centrifuged for 15 min at 10,000 rpm. 
The resulting supernatent was placed in the wells using 
a Hamilton microliter syringe (Hamilton Company, Reno, 
Nevada 89520). 
B. Slab gel electrophoresis 
Gels were prepared using a Hoefer molded vertical 
slab electrophoresis unit with casting stand (Hoefer 
Scientific Instruments, San Francisco, California 
94107). Dimensions of the gels were as follows: 14 cm 
wide, 16 cm long, 1.5 cm thick. Formulas for all 
so lutions may be found in Appendix B. 
The lower, resolving gel contained 12% acrylamide 
and was prepared by combining 16.25 ml of lower gel 
buffer with 26.00 ml acrylamide solution and 22.75 ml 
distilled water. This was mixed by swirling and 
deaerated by applying a vacuum for 15 min. Fresh 10% 
ammonium persulfate was prepared and 110 5 µl added to 
1 1 the monomer solu~ion as well as 16 9 µl of N,N,N , N -
tetramethylethylenediamine (TEMED) to catalyze 
polymerization. This solution was swirled gently to mix 
and placed between 2 glass "sandwiches" in the casting 
s tand . A 50 ml syringe was used to aspirate the 
solution and deliver it to a height about 4.0 cm from 
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the top of each of two "sandwiches." A layer of water 
was added in the same way and the gels allowed to 
polymerize overnight. 
The next morning the gel surface was rinsed once 
with water and the 5% stacking gel prepared. Distilled 
water (14.30 ml) was mixed with 6.25 ml stacking gel 
buffer and 4 . 29 ml acrylamide solution and deaerated as 
above. The separating combs were placed at an angle 
between the glass plates in each "sandwich." 
Polymerization was initiated by adding 75 .00 µl of 
ammonium persulfate and 25.00 µl TEMED to the stacking 
gel solution. This was then delivered using a 50 ml 
syringe to a level about 2 cm below the top of each 
"sandwich." The combs were then slowly pushed into the 
solution and centered. The level of monomer solution 
was adjusted to fill the "sandwich". After 
polymerization was complete (60-90 min), the combs were 
removed and the wells rinsed once with distilled water. 
The upper buffer chamber was attached to the top of 
the glass plate assemblies in the casting stand and 
fill ed with running buffer to cover the central ridge 
(approximately 600 ml) . The l ower buffer chamber was 
fi lled with about 1200 ml of running buffer, the heat 
exchanger placed inside, and cool tap water flow 
initiated . A stir bar was added to the lower buffer 
chamber, the unit placed on a magnetic sti rrer, and the 
glass plate assemblies placed inside the lower buffer 
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chamber 
Samples were added to the wells as follows: wells 
1 and 10, blank; wells 2 and 9, 25 µl standard; and 
wel ls 3 through 8, 5, 10, 15, 20, 25 and 30 pl of either 
the virulent or avirulent preparation. The electrode 
leads were attached and the power supply (Model 500, E-C 
Apparatus Corporation, St. Petersburg, Florida 33709) 
set to provide a constant current of 30 ma (15 ma/ gel) 
until the tracking dye reached the bottom of the 
stacking gel and then 60 ma (30 ma/ gel) until the dye 
reached the bottom of the resolving gel . Total r unning 
time was between 3 and 4 h . When the run was complete 
the power supply was turned off, the leads disconnected, 
and each gel placed in a plastic dish containing 400 ml 
of 40% methanol-10% acetic acid (v/ v) fixative solution. 
The containers were covered and gels stored until 
sta ined (no longer than 48 h). 
C. Gradient Gel Electrophoresis 
Precast gradient (3-27%) SDS-polyacrylamide gels 
(Sepragel @)) were purchased from Integrated Separation 
Systems (Newton, Massachusetts 02164). Gels were 
pl aced in the Hoefer casting stand us ing the alignment 
s pacers and slide clamps as directed by the package 
i nstructions. A sample applicator ( Sepracomb R.' ) was 
p laced on top of each gel, the upper buffer chamber 
attached and filled as above, and any bubbles inside 
each sample well removed according to the instructions. 
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The gels were placed inside the lower buffer chamber 
prepared as above. Samples were added to each well as 
follows: wells l, 2, 12, 13 - blank; wells 4, 7, 10-25 
pl standard; wells 3, 6, 9-20, 25, and 30 µl of the 
v irulent sample; and wells 5, 8, 11-20, 25 and 30 µl of 
the avirulent sample. The power supply was turned on 
and the current adjusted to 60 ma (30 ma/gel) until the 
tracking dye reached the bottom of the gel (about 3 
hours). Gels were removed and placed in the fixative as 
described above. 
D. Staining the Gels 
Gels were stained using the Bio-Rad Silver stain 
kit according to the directions for > 1.0 mm gels. Gels 
were gently rotated using a rocker platform (Bellco 
Biotechnology, Vineland, New Jersey 08360) throughout 
the entire staining process. Briefly, following 12-48 h 
of room temperature fixation, gels were immersed in two 
changes (400 ml each) of 10% ethanol-5% acetic acid 
(v/v) for 30 min each. Following the second period, 
gels were each immersed in 200 ml oxidizer for 10 min 
followed by 3 washes in 400 ml deionized water for 10 
min each. Gels were then immersed in 200 ml silver 
reagent for 30 min and washed for 2 min in 400 ml 
deionized water. Developer (200 ml) was then added and 
allowed to remain until the solution turned yellow or a 
brown "smokey" precipitate appeared (about 30 sec). 
This developer was discarded and 200 ml of fresh 
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developer added, and incubated 5 min. This was followed 
b y another 5 min incubation in 200 ml of fresh 
developer. The reaction was stopped using 400 ml of 5% 
acetic acid (v/v) for 5 min. Gels were stored in about 
10 ml of distilled water in Ziplo~ bags (Dow Chemical 
c ompany, Indianapolis, Indiana 46268) until 
photographed with a Polaroid camera. 
Serological Studies 
A. Monoclonal antibody analysis 
Organisms were tested using the monoclonal antibody 
in the direct immunofluorescent antibody kit of Genetic 
Systems (Seattle, Washington 98121) according to 
package directions. Both virulent and avirulent 1..,_ 
pneumophila were grown on BCYE at 37C in a 5% co2 
atmosphere and tested at the following times: 25 h, 48 
h, 72 h, 8 days, and 17 days after inoculation. A 
culture of~ coli incubated as above and tested at the 
same intervals was used as a negati v e control. A 
separate slide was used for each test. Slides were 
examined using an American Optical vertical fluorescence 
microscope, model 2071 (Reichert Scientific Instruments, 
Buffalo, New York 14215) equ ipped with a filter system 
for fluorescein isothiocyanate. 
B. Polyclonal antibody anal ysis 
Organisms were tested u sing the direct 
immunofluroescent polyclonal antibody kit produced by 
Litton Bionetics, Inc (Cha r leston , South Carolina 
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29405) according to package directions. Virulent and 
avirulent ~ pneumophila and ~ coli were tested as 
described above . 
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RESULTS 
Virulence of the organisms was confirmed in the 
ini tial guinea pig studies. The animal which received 
the suspension of virulent h pneumophila (5.2 x 10 8 
colony forming units [CFU]) exhibited signs of infection 
including ruffled fur, eye discharge, and listlessness 
withi n 48 h and became moribund approximately 51 h after 
injection. This guinea pig (GP #1) was sacrificed and 
the spleen and liver cultured. After 5 days, heavy 
growth of what appeared to be h pneumophila was 
obse rved. Gram stain of the isolate (Figure 4) showed 
typical morphology and a direct fluorescent antibody 
stain confirmed the finding. This isolate was injected 
(2 x 108 CFU) into another animal which succumbed in a 
manner similar to the first. Cultures of this animal's 
spleen and liver (GP #2) also yielded a heavy growth of 
h pneumophila. Isolates from both animals were passed 
onc e a week on BCYE and EYB agars. 
The avirulent h J2.D.~umophila failed t o affect a 
guinea pig when 9.0 x 10 8 CFU were injected. This 
ani mal remained apparently healthy until sacrificed 7 
days after inoculation . Cultures of tissues from this 
animal yielded 30 colonies from the spleen homogenate 
and 2 from the liver which were identified as L. 
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Figure 4 
Typical Gram Reaction of Virulent or Avirulent 
Legionella pneumophila Isolated on BCYE Agar 
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E!leumophila. 
Results of the media evaluation study are shown in 
Table 3. Since the animal which received the isolate 
from GP #1 passed 20 times on CYE remained healthy while 
the 26th passage on this medium killed within 48 hours, 
the 25th passage of the isolate from GP #2 was tested. 
The results of this experiment are shown in Table 4. 
Table 5 shows the results of polymixin B treatment 
of the virulent L. pneumophila. Of the two guinea pigs 
inoculated with the initial suspension, one died within 
48 h, the other appeared to be unaffected throughout the 
observation period. All 4 animals inoculated with the 
10-fold dilutions died within 5 days. Two animals 
receiving the 100-fold dilutions (one received the 
saline-treated suspension, the other, the polymixin B 
treated organisms) exhibited signs of illness including 
lethargy, eye discharge, and labored breathing. The 
other animal in each pair remained apparently well 
throughout the 10 days. 
Treatment of the avirulent L. pneumophila with 
polymixin B resulted in no deaths and no apparent 
illness in either of the animals which received the 
polymixin B-treated or the saline treated organisms 
(Table 6). Since an occasional animal appeared to be 
unaffected by usually lethal amounts of the virulent 
bacteria (Tables 3, 4, and 5) blood was drawn by cardiac 
puncture from these animals one day prior to injection 
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Table 3 
Ability of Virulent L. pneumophila* to Affect Guinea 
Pi gs Following Continuous Passage on BCYE or EYB Agar 
Pas sages Organisms Injected (CFU)* Outcome 
26 
CYE 
EYB 
CYE 
EYB 
CYE 
EYB 
8.7 x 108 
4.8 x 108 
7.0 x 108 
3 . 6 x 108 
4.7 x 108 
6.1 x 108 
*bacteri a original ly isolated from GP #1. 
moribund at 2 days 
moribund at 2 days 
alive and well at 7 
days 
dead at 4 days 
dead at 2 days 
dead at 5 days 
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Table 4 
Ability of Virulent L. pneumophila* to Affect Guinea Pigs 
Following 25 Passages on BCYE or EYB Agar 
Med ium Organisms Injected (CFU) Outcome 
CYE 3.5 x 10 8 dead at 2 days 
3.5 x 10 7 dead at 3 days 
EYB 1. 4 x 10 8 dead at 3 days 
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1. 4 x 10 7 alive and well at 
7 days 
*bacteri a o riginally isolated from GP #2 
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Table 5 
The Eff ect of Polymixin B Treatment of Known Virulent Legionella 
pneumophila on Guinea Pig Morbidity and Mortality 
E_l!spens i on 
undiluted 
10-fold 
dilution 
polymixin B 
treated 
10-fold 
dilution 
saline treated 
100- fol d 
dilution 
pol ymixi n B 
trea ted 
Colony Count (CFU) Outcome 
Pre- Post-
treatment treatment 
5 5 x 10 8 3 . 2 x 10 8 1 dead at 2 days 
ND* 
ND 
ND 
1 alive and well at 
10 days 
3 . 5 x 10 7 2 dead at 4 days 
2.6 x 10 7 1 dead at 4 days 
1 dead at 5 days 
2 .5 x 10 6 1 sick days 3-6 ; 
recov ered 
1 ali v e and well at 
10 days 
100- fol d ND 2.4 x 10 6 1 si c k days 2-6; 
dilution recov ered 
saline treated 1 aliv e and well at 
10 days 
*ND = no t done 
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Table 6 
Effect of Polymixin B Treatment of Known Avirulent 
~jonella pneumophila on Guinea Pig Morbidity and Mortal i ty 
sus12ensi on Colony Count (CFJU Outcome 
Pre- Po st-
treatment treatment 
Pol ymixin B l. 3 x 1 0 9 5 . 9 x 10 8 2/ 2 a live and 
treated we l l at 7 
days 
Saline treated l. 3 x 10 9 9 1 x 1 0 8 2/ 2 a live and 
we ll at 7 
d a ys 
The sera were tested for the presence of antibodies 
specific for k:_ pneumophila using an indirect 
fluorescent antibody technique. One animal in each 
tre atment group had a titer less than 1:16 while the 
other had a weak reaction at 1:16 only. 
Early experiments with the hogchoker (Trinecte 
macu latus) to test virulence used organisms prepared so 
tha t 0.3 ml of a suspension containing approximately 10 8 
CFU/ml was injected per fish. None of the fish so 
inoculated were infected. Subsequent experiments used 
all bacteria which could be removed from one BCYE plate 
streaked for confluent growth suspended in 10 ml of 0.7% 
sal ine. The effects of injecting 0.3 ml of this 
suspension as well as three serial 10-fold dilutions 
into the hogchoker are shown in Table 7. Those fish 
injected with the virulent k:_ pneumophila were housec 
separately from those receiving the avirulent strain due 
to the large numbers of fish involved. The fish began 
to die in both tanks in an apparently random manner 
after 6 days. The peritoneal cavity of each was 
cul tured as soon as the death was observed 
resul ts are shown in Tables 8 and 9. 
Culture 
Virulent k:_ pneumophila was recovered from 9 of the 
12 fish inoculated with this strain. One fish was not 
cultured; 82% of those in which cultures were obtained 
had at least a few viable k:_ ~umophila and 4 fish had 
large numbers. The two in which the organism was not 
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Table 7 
Mortality of Hogchoker (Trinecte maculatus) Infected 
with Virulent or Avirulent Legionella pneumphila* 
Organisms Ir_Dected (CFU)** Deaths at 6 
Vi rulent 
h .P_neumophi 1 a 
Uninoculated Controls 
Avirulent 
h pneumophila 
Uninoculated Controls 
7.5 x 10 8 
7.5 x 10 7 
7.5 x 10 6 
7 . 5 x 10 5 
0 
3 . 3 x 10 9 
3.3 x 10 8 
3.3 x 10 7 
3.3 x 10 6 
0 
0 / 3 
0 / 3 
0 / 3 
1/ 3 
0/ 3 
C/ 3 
0/ 3 
0 / 3 
0 / 3 
0/3 
* fish injected with each strain were kept in separate 
tanks 
** total volume injected was 0.3 ml per fish in each 
case 
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Table 8 
Recovery of Virulent Legionella pneumophila from the Peritoneal 
c avities of Hogchoker Inoculated with Varying Numbers of 
Organisms 
Numbe r o f Organisms 
Ini e c ted ( CFU l 
Time of Death 
(days) 
Culture Results* 
* 
7 5 x 10 8 7 3 + L. pneumophila 
11 1 colony (not legionella) 
14 2 + L. pneumophila 
(sacrificed) 
7 5 x 10 7 7 1 + L . pneumophi l a 
7 1 + L. pneumophila 
11 no growth 
7 5 x 10 6 9 2 + L . pneumophi l a 
9 3 + L . pneumo12hila 
11 4 colonies (not 
legionella) and 
1 + L. pneumophila 
7 5 x 10 5 5 not done 
8 1 + mi xed flora 
11 2 + mixed flora 
Un inoculated 7 2 colonies (no t 
leg i onellae) 
8 2 + mi xed flora 
11 1 + mixed fl o ra 
l+ 
== colonies in primary streak only 
2 + 
3+ = 
== 
colonies in primary and secondary s t reaks only 
colonies in all three streaked areas 
4+ 
== nearly confluent growth in all str eaked areas 
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Table 9 
Recove ry of Avirulent Legionella pneumophila from the Peritoneal 
Cavities of Hogchoker Inoculated with Varying Numbers 
of Organisms 
Number of Organisms 
_l!!jec ted (CFU) 
Time of Death Culture Results* 
(days) 
3 3 x 10 9 
3 3 x 10 8 
3 3 x 10 7 
3 3 x 10 6 
9 4 + L. pneumophila 
9 
9 
7 
14 
14 
(sacrificed) 
7 
9 
9 
7 
8 
9 
4 + L. pneumophila 
3 + L. pneumophila 
2 + mixed flora 
3 + mixed flora 
2 + L. pneumophila 
3 + L. pneumophila 
3 + ~eumophila 
3 + ~eumophila 
2 + L. pneumophila 
2 colonies (not legionella) 
and 1 + ~eumophila 
2 + L . pneumophila 
Uninoculated 8 4 colonies (not legionella) 
* l+ 
2+ 
== 
3+ 
4+ 
== 
9 no growth 
11 3 + mixed flora 
colonies in primary streak only 
colonies in primary and secondary streaks only 
colonies in all three streaked areas 
nearly confluent growth in all streaked areas 
recovered both received the lowest number initially. 1_,_ 
.Q_neumophila was not isolated in any of the uninoculated 
fish housed in the same tank. This was also the case 
with the uninoculated controls in the tank containing 
those fish which received the avirulent form. 1_,_ 
pneumophil a was reisolated from 10 of the 12 fish (83%) 
inoculated with the avirulent form. These fish had 
generally higher numbers of 1_,_ pneumophila than did 
those which received the virulent strain. The two fish 
in which the avirulent 1_,_ pneumophila was not isolated 
received an intermediate number (3 3 x 108 ) initially. 
Both hogchoker and spot (Leiostomus xanthurus) 
became readily available, so the next experiments 
involved simultaneous testing of both species. 
Suspensions of virulent 1_,_ pneumophila were prepared as 
above and 0.3 ml of each as well as 0.3 ml of two serial 
ten-fold dilutions were injected into both species. 
On ly the hogchoker received the avirulent strain; these 
fish were housed in another aquarium. The results of 
this experiment are shown in Table 10 . Since only one 
death occurred in 7 days, on day 8 two fish each from 
the groups that received the undiluted original 
suspensions were sacrificed and the peritoneal cavities 
cultured . The culture results are shown in Table 11. 
Remaining fish survived until the experiment was 
te rminated on day 10. 
Table 12 shows the results of this experiment 
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Table 10 
Mortal ity of Hogchoker (Trinecte maculatus) and Spot (Leiostomus 
xanthurus) Infected with Virulent or Avirulent Legionella 
pneumophila* 
Virulent 
h pneumophila 
Avirulent 
L i;:>neumophila 
Organisms Injected 
(CFU)** 
1. 2 x 10 10 
1. 2 x 10 9 
1. 2 x 10 8 
Uninoculated 
5. 2 x 10 8 
5.2 x 10 7 
5.2 x 10 6 
Uninoculated 
Deaths in 7 Days 
Hog Choker Spot 
0/ 3 
0/ 3 
0/ 3 
0/ 4 
0/ 3 
0/ 3 
0 / 3 
0/ 3 
0/ 3 
0/ 3 
1/ 3 
0 / 3 
ND 
ND 
ND 
* f ish i njected with each stra i n were h oused in separate tank s 
** total v olume inj ected wa s 0 . 3 ml per f i sh in each c ase 
not done 
Table 11 
Recovery of Virulent or Avirulent Legionella pneumophila 
fr om the Peritoneal Cavities of Hogchoker and Spot 7 Days 
After Inoculation with Known Numbers of Organisms 
Organisms 
Injected (CFU) 
Virulent 
L. pneumophila 1. 2 x 10 10 
Hogchoker #1 
#2 
Spo t #1 
#2 
Aviru lent 
}:.. . pneumophi 1 a 5 2 x 10 8 
Hogchoker #1 
#2 
colonies in primary streak only 
Culture results * 
3 + L. pneumophila 
3 + L. pneumophila 
2 + L. pneumophila 
2 + L. pneumophila 
1 + L. pneumophila 
2 + L. pneumophila 
* 1+ = 
2+ 
3+ = 
4+ 
colonies in primary and secondary streaks only 
colonies in all three streaked areas 
nearly confluent growth in all streaked areas 
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Table 12 
Mortality of Hogchoker and Spot Infected with Virulent 
or Avirulent Legionella pneumophila (0.3 ml Dose) 
and Housed in the Same Tank 
Organisms Deaths in 7 Days 
Injected (CFU)* Hogchoker Spot 
Virulent h pneumophila 1. 1 x 1010 0/3 1/ 3 
Aviru lent h pneumophila 1. 4 x 1010 0/ 3 1/3 
Uninocu lated Controls 0 0/2 2/4 
*total volume injected was 0.3 ml per fish in each case 
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repeated with these modifications: all fish were housed 
in the same tank, both species received identical 
inoculations, and 0.3 ml of only the original, undiluted 
suspensions was injected into each Mortality was 
similar for the hogchoker; however, there was one death 
wi thin 48 h in each spot group. The volume of each 
inoculum was next increased to 0.5 ml. This resulted in 
only one hogchoker death but 8 of the 9 injected spot 
di ed within 48 h (Table 13). 
Table 14 shows the mortality of spot only injected 
wi th 0.5 or 0.4 ml of either the virulent or avirulent 
~ pneumophila. Since any deaths which appeared to be 
re lated to the inoculation occurred within 48 h, this 
pe riod was used to determine mortality in this 
experiment. Although both the virulent and avirulent 
groups experienced significant numbers of deaths, th~re 
appeared to be some time relationship Table 15 shows 
the number of deaths as they occurred at 24, 36, and 48 
h (spot only) in both this and the previous experiment . 
Smears of peritoneal material were stained with Wright's 
stain and then Giemsa's stain at the time of death in 
thi s experiment. Control fish and those still alive 
which received the av irulent ~ pneumophila were 
sacrificed and smears made. Figure S shows a typical 
fi eld seen in peritoneal smears of the sacrificed 
control fish. Cells were few in number and primarily 
red blood cells. Occasional leukocytes were seen; most 
Table 13 
Mortality of Hogchoker and Spot Infected with Virulent 
or Avirulent Legionella pneumophila (0.5 ml Dose) 
and Housed in the Same Tank 
8 7 
Organisms Deaths in 7 Days 
Injected (CFU) * Hogchoker Spot 
Virulent h pneumophila 1. 0 x 10 10 0/ 3 5/ 5 
Avirulent L. pneumophila 1. 5 x 10 10 1/ 3 3/ 4 
Uninoculated Controls 0 0/3 0/ 4 
*total volume injected was 0.5 ml per fish in each case 
Table 14 
Mortality of Spot (Leiostomus xanthurus) Infected with 
Two Different Volumes of Virulent or Avirulent 
Legionella pneumophila and Housed in the Same Tank 
Volume Organisms 
88 
Injected (ml) Injected (CFU) Deaths in 48 hours 
Virulent 0.5 1. 3 x 10 10 4/ 4 
strain 
10 1 0 0.4 1. 0 x 4/ 4 
Avirul ent 0.5 1. 8 x 10 10 3/ 4 
strain 
0.4 1. 5 x 10 10 1/ 4 
Uninocu lated 
Control s 0 0 0/ 5 
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Figure 5 
Wright-Giemsa Stained Smear of Peritoneal Cavity 
of Uninoculated Spot 
(original magnification, 400X) 
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appeared to be macrophages (Figure 6). The fish 
injected with the avirulent !;_,__ pneumophila showed a more 
cellular infiltrate. Cells seen in fish which were 
found dead exhibited degenerative changes and were 
difficult to identify. The one fish alive at 48 h which 
rece ived 0.5 ml was sacrificed; representative fields 
from this fish ' s peritoneal smear are seen in Figures 7, 
8, and 9. Erythrocytes were seen as in the control, but 
more leukocytes were apparent. A variety of types were 
seen , predominately macrophages and lymphocytes, 
although a few granulocytes were also observed. Clumps 
of mononuclear cells (Figures 10 and 11) were found as 
wel l . All fish inoculated with the virulent strain were 
found dead. Similar degenerative changes were seen and 
cel l types were very difficult to differentiate. 
Representative fields are shown in Figures 12 and 13. 
No erythrocytes were identified, but a few mononuclear 
cel ls were seen . Occasional sheets of cells with 
indi stinct cytoplasmic borders (Figures 14, 15 and 16) 
we r e observed as well. 
The spot were also used t o determine the effects o f 
serial p assages on BCYE on the v iru lence of t he 
bacteria. All fish (includin g c ontrols) were f ound dead 
a t 24 h (Table 16 ). 
Tank water c ultured 2 4 h after fish were inoc u lated 
a nd fil t ers cultured at the e nd o f each experiment 
yielded no detectable 1-.:_ gneumoph i la at any time. 
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Figure 6 
Wright-Giemsa Stained Smea r of Peritoneal Cavity of 
Uninoculated Spot 
(original magnificati o n 1,000 X) 
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Figure 7 
Wright-Giemsa Stained Smear o f Peritoneal Cavity of 
Spot Sacrificed 48 Hours After Inoculation with 
l.8Xlo10 Avirulent Legionella pneumophila 
(original magnification 400 X) 
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Figure 8 
Wright-Giemsa Stained Smear of Peritoneal Cavity of Scfot 
Sacrificed 48 Hours After Inoculation with l.8Xl01 
CFU Avirulent Legionella pneumophila Demonstrating a 
Mononuclear Cell (original magnification 1,000 X) 
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Figure 9 
Wright -Giemsa Stained Smear of Peritoneal Cavity of Spot 
Sacrificed 48 Hours After Inoculation with 1 8Xl0 10 
CFU Avirulent Legionella pneumophila Demonstrating 
Two Mononuclear Cells 
(original magnification 1000 X) 
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Figure 10 
Wright-Giemsa Stained Smear of Peritoneal Cavity of Spot 
Sacrificed 48 Hours After Inoculation with l.8Xl Q1DcFU 
Avirulent Legionella pneumophila Showing Clumps of 
Mononuclear Cells 
(original magnificati on 400 X) 
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Figure 11 
Wright-Giemsa Stained Smear of Peritoneal Cavity of Spot 
Sacrificed 48 Hours After Inoculation with l.8Xlol0cFU 
Avirulent Legionella pneumophila Showing Clumps of 
Mononuclear Cells 
(original magnificati on 1,000 X) 
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Figure 12 
Wright-Giemsa Stained Smear o f Peritoneal Cavity of Spot 
Dead 48 Hours After Inoculation with l.3x1d° CFU Virulent 
Legionella pneumophila-Representativ e Field 
(original magnification 400 X) 
98 
Figure 13 
Wright-Giemsa Stained Smear of Peritoneal Cavity of Spot 
Dead 48 Hours After Inoculation with l.3Xl60 CFU Virulent 
Legionella pneumophila - Another Representative Field 
(original magnification 400 X) 
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Figure 14 
Wright-Giemsa Stained Smear of Peritoneal Cavity of Spot 
Dead 48 Hours After. Inoculation with l . 3Xlol0cFU Virulent 
Legionell~ pneumophila Demonstrating Sheets of Cells 
(original magnification 100 X) 
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Figure 15 
Wright-Giemsa Stained Smear of Peritoneal Cavity of Spot 
Dead 48 Hours After Inoculation with l.3Xld0 CFU Virulent 
Legionella pneumophila Demonstrating Sheets of Cells 
(original magnification 400 X) 
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Figure 16 
Wright-Giemsa Stained Smear of Peritoneal Cavity of Spot 
Dead 48 Hours After Inoculation with l.3X1Ql0 CFU Virulent 
Legionella pneumoohila Demonstrating Another Sheet of 
Cells (original magnification 400 X) 
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Table 16 
Abi li ty of Virulent Legionella pneumophila to Kill Spot After 2 
and 27 Transfers on BCYE Agar 
Volume Organisms 
Injected (ml) Injected (CFU) peaths 
2 Transfers 0.5 1. 7 x 10 10 5/ 5 
0 . 4 1.4 x 10 10 5/ 5 
27 Transfers 0.5 1 x 10 10 5/ 5 
0.4 8 x 10 9 5/ 5 
Uninoculated Controls 0 0 6/6 
Legionellaceae are known to survive in fresh water, 
so before virulence studies were begun using the fresh 
water fish, it was necessary to determine whether the 
bacteria would multiply under the test conditions. 
Addition of 10 6 CFU of virulent or avirulent 1_,_ 
pneumophila to 99 ml of tap water (final bacterial 
concentration: 10 ~ml) resulted in the reisolation of no 
detectable 1_,_ pneumphila of either strain, even after 7 
days of incubation at room temperature (Table 17). 
The golden shiner minnows (Notemigonus crysoleucas) 
were initially injected with 0.5 ml and 0.3 ml of 
bacterial suspensions prepared as in the hogchoker and 
spot studies. All inoculated fish died within 4 days 
(Table 18). Peritoneal cultures of fish which died 24 
hours or more after inoculation are shown in Table 19 as 
well as the three living control fish which were 
sacrificed on day 4. No 1_,_ pneumophila was isolated 
from the uninoculated controls but was recovered from 11 
of 13 (84.6%) of the inoculated fish. Minnows were then 
injected with 0.1 ml of the bacterial suspension. Since 
the fish still died rapidly (Table 20), the next 
experiment used 0.1 ml of a 10-fold dilution of the 
original suspension as well. Results are shown in Table 
21 . None of the fish receiving the avirulent strain 
died within 10 days. Two of the fish receiving the 
undiluted suspension of virulent bacteria died within 
24 h, the third was dead within 4 days, and the fourth 
104 
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Table 17 
Recovery of Virulent and Avirulent Legionella pneumophila After 
Inocu lation in Carbon-Filtered Richmond City Tap Water Followed 
by Incubation at Room Temperature 
Day 
0 (prior to inoculation) 
1 
2 
3 
4 
5 
6 
7 
Organisms Isolated (CFU x 10 4 ) 
L.pneumophila/ Total* 
Virulent** Avirulent** 
0/ 1. 6 0/ 1.6 
0/ 51 0/ 41 
0/ 107 0/ 88 
0/ 43 0/ 36 
0/ 58 0/ 36 
0/ 16 0/ 16 
0/ 34 0/ 35 
0/ 50 0 / 25 
* Av erage of duplicate cultures of 
o f each sample 
- 2 - 4 6 10 , 10 , 10- dilutions 
6 
** 3 6 x 10 CFU Virulent bacteria suspended in 1 ml of 0. 7% 
s aline added to 99 ml water 
6 4 . 7 x 10 CFU Avirulent bacteria suspended in 1 ml of 0. 7% 
saline added to 99 ml water 
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Table 18 
Mortality of Golden Shiner Minnows (Notemigonus crysoleucas) 
Inocu lated with 0.5 ml or 0.3 ml Doses of Virulent or Avirulent 
Legionella pneumophila and Housed in the Same Tank 
Volume Organisms 
Injected (ml) Injected (CFU) Deaths After 4 Days 
Virulent 
10 10 strai n 0.5 1. 5 x 4/ 4 
0.3 9.3 x 10 9 4/ 4 
Aviru lent 
10 10 s trai n 0 . 5 1. 0 x 4/ 4 
0 . 3 6.3 x 10 9 4/ 4 
Uninoculated 
Contro ls 0 0 1/ 4 
Table 19 
Recovery of Legionella pneumophila from the Peritoneal 
Cavities of Minnows Inoculated with Varying Numbers of 
Organisms Which Died 24 or More Hours After Injection 
Time of Death Number of Organisms 
Injected (CFU) (days) Culture Results* 
Virulent strain 
1. 5 x 10 10 
9 9.3 x 10 
Avirulent strain 
1.0 x 101 0 
6.3 x 109 
Uninoculated Controls 
1 
2 
1 
1 
2 
3 
1 
1 
1 
1 
1 
1 
4 
4 
(sacrificed) 
4 
(sacrificed) 
4 
(sacrificed) 
* l+ colonies in prim~ry streak only 
3+ 
2+ 
3+ 
3+ 
2+ 
3+ 
3+ 
3+ 
3+ 
3+ 
3+ 
3+ 
3+ 
3+ 
2+ 
l+ 
L.pneumophila; 
l+ mixed flora 
L.pneumophila; 
l+ mixed flora 
L.pneumophila 
L.pneumophil'! 
mixed flora 
mixed flora 
L. pneumophila 
L. pneumophila 
L. pneumophila 
h_Bneumophila 
L.pneumophila 
L.pneumophila; 
l+ mixed flora 
L. pneumophila 
mixed flora 
mixed flora 
mixed flora 
2+ 
3+ 
= 
= 
colonies in primary and secondary streaks only 
colonies in all three streaked areas 
4+ = nearly confluent growth in all streaked areas 
** 
** = isolate appeared typical of L. pneumophila; however, the 
organisms failed to grow on subculture 
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Table 20 
Mortality of Golden Shiner Minnows Inoculated With 0.1 ml 
Doses of Virulent or Avirulent Legionella pneumophila and 
Housed in the Same Tank 
108 
Organisms Injected (CFU) Deaths After 7 Days* 
Vi rulent strain 4. 6 x 10 9 4/ 4 
Avirulent strain 5 . 8 x 10 9 2/ 4 
Uninoculated Controls 0 0/ 4 
*All deaths occurred with the first 36 h; remaining fish were 
sacrificed at 7 days. 
Table 21 
Mortality of Minnows Inoculated With 0.1 ml Doses of 
Undiluted or a 1:10 Dilution of Virulent or Avirulent 
Legionella pneumophila and Housed in the Same Tank 
Organisms Injec~ed (CFU) Deaths After 10 
Virulent strain 
4.4 .x: 109 3/ 4 (8h, 24h, 
day 4) 
4.4 .x: 108 1/ 4 (day 7) 
Avirulent strain 
5.3 .x: 109 0/ 4 
5 . 3 .x: 108 0/ 4 
Uninoculated Controls 0 1/3 (day 2) 
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Days 
and 
did not succumb within the 10 days. Only 1 of the 4 
which received the 10-fold dilution died in the 10 days; 
this death occurred on day 7. The peritoneal cavity of 
one surviving fish in each group was cultured on day 10. 
1._,_ pneumophila was reisolated from all except the one 
which received the 10-fold dilution of the avirulent 
strain (numbers varied from 4 to 45 colonies). 
There appeared to be some changes in the ability of 
the virulent L. pneumphila to kill consistently when 
similar numbers of bacteria were injected. The age of 
the BCYE agar was suspected to be the culprit. To test 
this hypothesis, the virulent strain only was cultured 
on media stored for 2 months at 4 C and on plates 
prepared within 72 h. The results of this experiment 
are shown in Table 22. 
Tank water was cultured daily in all experiments 
except the last. Legionellaceae were isolated 
sporadically from the water and only in the first two 
days following inoculation (Table 23). Filter cultures 
resulted in heavy growth, but no 1._,_ pneumophila was 
isolated, e v en from subcultures of the original plates. 
Chemotactic activity of human mononuclear cells 
directed toward both strains was more than the negative 
control, but still less than that with the E. coli 
(Table 24). Using 2.5 times the control mean (12.3) as 
the minimum for a positive result, both the E.coli and 
the avirulent 1._,_ I?_neumophila would be considered to be 
110 
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Table 22 
Mortality of Golden Shiner Minnows Injected with 0.1 ml Doses 
o f Virulent Legionella pneumophila Grown on Fresh or 
Two-Month-Old BCYE Agar and Housed in the Same Tank 
Organisms Injected (CFU) Deaths After 7 Days* 
Fresh BCYE 1. 3 x 10 9 2/ 5 
Old BCYE 1. 6 x 10 9 4/ 5 
Uninoculated 
Contro ls 0 0/ 4 
* All deaths occurred within the fi r st 24 hours . 
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Table 23 
Recovery of Leqionella pneumophila from Water and Charcoal 
Filters in Tanks Used to House Golden Shiner Minnows 
Number of Fish 
Volume Injected (ml) 
Water, Day* 
0 
1 
2 
3 
4 
5 
6 
Filter** 
Organisms Isolated (CFU x 103 ) 
L. pneumophila/Total 
Tank 1 Tank 2 Tank 3 
20 12 19 
0.5, 0.3 0.1 0.1 
0/160 0/ 47.5 0/ 20.0 
>100/TNTC 4.5/ 50.0 0/ 25.0 
2.5/ TNTC 0/ 55 0 3.5/ 15.0 
O/ TNTC 0/ 45.0 0/ 6.0 
0/ 10.5 0/75.0 0/ 2 . 0 
ND 0/ 62 . 5 0/ 5.0 
ND 0/ 27 . 5 0/ 14.5 
O/ TNTC O/ TNTC O/ TNTC 
* Wate r was tested at two dilutions (10- 2 and 10- 4 ) in duplicate 
using BMPA a medium and the results averaged except in the 
first tank where only the 10-2 dilution was cultured. Results 
are rounded to the nearest 500. 
** Filters were swabbed and plated directly onto BMPA a medium 
in duplicate. In all instances there was nearly confluent 
growth and no L. pneumophila could be isolated on subcultures. 
113 
Table 24 
Chemotactic Index of Human Mononuclear Cells Toward Two Strains 
of Legionella pneumophila 
Chemotactic Index 
Virulent Strain Avirulent Strain 
Experiment 
1 8.1 13.1 
2 14.9 16 . 2 
3 12.7 16.8 
4 8.2 11. 4 
Mean o f all Experiments 11 14.4 
Va lues are expressed as the ratio of mononuclear cell s on the 
l ower surface of the filter to the total number of mononuc l ear 
c e lls counted. Each v alue represents the mean o f duplicat e 
chambers. Negativ e control mean was 4 . 9 and the E . c o li mean was 
19 2. 
chemotactic, while the virulent strain would be 
borderline, but negative. 
114 
Guinea pig peritoneal macrophages were attracted to 
all three organisms tested (Table 25). The virulent 1...,_ 
pneumophila strain, however, would not be considered 
positive in relation to the negative control (2.5 times 
the control mean= 11.0). Both the h coli and the 
avirulent 1...,_ pneumophila would be considered to be 
positive with the _g:__,_ coli slightly less chemotactic. 
The hogchoker macrophages reacted positively at 90 
min with the h coli and the virulent 1...,_ pneumophila, 
but not the avirulent 1...,_ pneumophila (2.5 times the 
negative control mean= 20.8), as seen in Table 26. The 
h coli chemotactic index was nearly twice that of the 
virulent strain, which only minimally exceeded the 
control value standard. The reverse was the case with 
the spot macrophages (Table 27). The avirulent strain 
was the most chemotactic of the three at 90 min, which 
were all positive using a value of 20 to determine 
chemotactic activity. None of the bacteria tested 
produced chemotactic activity which exceeded that of the 
controls when the golden shiner minnow macrophages were 
used (Table 28). Table 29 compares the chemotactic 
responses of all species tested. 
Results of the plasmid analysis are seen in Figure 
17 . No plasmids were detected in either the virulent or 
the avirulent 1...,_ pneumophila. 
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Table 25 
chemotactic Index of Guinea Pig Peritoneal Macrophages Toward Two 
Strains of Legionella pneumphila 
Chemotactic Index 
Virulent Strain Avirulent Strain 
Experiment 
1 9.2 10. 6 
2 9.9 20.3 
3 5.0 10.0 
4 13.l 16.7 
Mean of all Experiments 9.3 14.4 
Va lues are expressed as the ratio of macrophages on the l0wer 
surface of the filter to the total number of macrophages counted. 
Each v alue represents the mean of duplicate chambers. Ne g ativ e 
contro l mean was 4.4 and the~ coli mean was 13.3. 
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Table 26 
Chemotactic Index of Hogchoker (Trinecte maculatus) Macrophages 
Toward Two Strains of Legionella pneumophila 
Chemotactic Index 
Virulent Strai n Av irulent Strain 
I ncubation Time 
30 minutes 20 . 3 5.5 
60 minutes 35 . 3 10.8 
90 minutes 21. 8 14.3 
Value s are expressed as the ratio o f macrophages on the lower 
su r face of the filter to the total number o f macrophages counted. 
Each v alue represents the mean of duplicate chambers from three 
experiments using 12-25 fish per experiment. Negative control 
mean was 8 . 3 and the E.coli mean was 38.5 at 90 minutes ' 
i ncubation t ime. 
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Table 27 
Chemotactic Index of Spot (Leiostomus xanthurus) Macrophages 
Toward Two Strains of Legionella pneumophila 
Chemotactic Index 
Virulent Strain Avirulent Strain 
Incubation Time 
30 minutes 10.5 25.7 
60 minutes 22 . 3 40.5 
90 minutes 24. 3 60.5 
Values are expressed as the ratio of macrophages on the lower 
surface of the filter to t h e total number of macrophages counted . 
Each v alue represents the mean of duplicate chambers from three 
exper iments using 12-25 fish per experiment. Negati v e Control 
mean was 8 and the E.coli mean was 38 at 90 minutes ' i ncuba tion 
time. 
Table 28 
Chemotactic Index of Golden Shiner Minnow (Notemigonus 
crysoleucas) Macrophages Toward Two Strains of 
Legionella pneumphila 
Chemotactic Index 
Virulent Strain Avirulent Strain 
Incubation Time 
30 minutes 7.1 5.1 
60 minutes 9.9 6.6 
90 minutes 6 . 5 5.9 
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Values are expressed as the ratio of macrophages on the lower 
surface of the filter to the total number of macrophages counted. 
Each v alue represents the mean of duplicate chambers from four 
~xperiments using 12-25 fish per experiment . Negative control 
mean was 11.3 and the E.coli mean was 3 at 90 minutes ' incubation 
time . 
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Table 29 
comp arison of Chemotactic Activity of Human Mononuclear Cells, 
Gui ne a Pig Macrophages, and Macrophages from Three Species of 
Fish Using Virulent or Avirulent k,_ pneumophila 
as the Stimulus 
Chemotactic Activity 
Virulent Strain Avirulent Strain 
Human Mononuclear Cells + + 
Gui ne a Pig Peritoneal 
Macrophages + 
Fi sh Macrophages 
Hog Choker + 
Spot + + 
Minnow 
Chemotaxis was considered positive (+) when test v alues exceeded 
2 5 t imes the control value . Chemotaxis was negative (-) if the 
value was less . Borderline values (~) were those which were + 
1 . 5 that o f the negative control value times 2.5 . 
Figure 17 
Analysis for the Presence of Plasmids in 
Virulent and Avirulent Legicnella pneumophila 
Lane 2 Avirulent Legionella pneumophila 
Lane 3 Virulent Legionella pneumoohila 
Lane 8 E .co li with multiple plasmids 
Lanes l, 4, 5, 6, and 7 contain environmental 
L. pneumophila isolates with known 
plasmid content 
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Both virulent and avirulent forms were similar 
morphologically. The virulent form (Figure 18) 
demonstrated the typical trilaminar outer membranes with 
evenly distributed nuclear material; large vacuoles were 
seen inside many of the cells. Only three cells were 
found to have any suggestion of a capsule (Figure 19) 
after prolonged searching. The avirulent 1_,_ pneumophila 
had a similar appearance with 2 differences. The 
intracellular vacuoles were smaller and usually less 
distinct (Figure 20) and apparently encapsulated 
organisms (Figure 21) were easily found. Polymixin B 
treatment of both strains also produced similar changes 
in morphology (Figures 22 and 23). Bleb formation was 
noted to be evenly distributed over the outer surfaces 
of the bacteria and the nuclear material was distributed 
in a patchwork pattern. 
Electrophoresis using a 12% sodium dodecylsulfate 
polyacrylamide gel (SDS-PAGE) to separate soluble 
proteins suggested the presence of several bands in the 
avirulent form that were not seen in the virulent 1_,_ 
pneumophila (see Figures 24 and 25). One additional 
band appeared to be p resent between the 3 1 and 45 kd 
standards, two between the 21.5 and 31 kd standards, and 
one at the same point as t h e 21.5 kd standard. An 
attempt was then made to clarify these bands as well as 
to separate possible additional bands using the more 
sensitive gradient SDS-PAGE. Results of electrophoresis 
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Figure 18 
Ultrastructure of Virulent Legionella pneumophila 
(70,000 X) 
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Figure 19 
Possible Encapsulated Virulent Legionella 
pneumophila (70,000 X) 
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Figure 2 0 
Ultrastructure of Avirulent Legi onella 
pneumophila (90,000 X) 
124 
125 
Figure 21 
Encapsulated Avirulent Legionell~ pneumophila (90,000 X) 
Figure 22 
Appearance of Virulent L. pneurnophila Foll owing 
Treatment with 160 µg/ rnl Polyrnixin B ( 70,000 X) 
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Figu re 23 
Appearance of Avirulent L. pneumophila Fo llowing 
Treatment with 160 ~g/ml Polymixin B (70,000 X) 
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Figure 24 
Pattern of the Soluble Proteins of Virulent Legionella 
pneumophila After 12% Sodium Dodecylsulfate 
Polyac=ylamide Gel Electrophoresis 
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Figure 25 
Pattern of the Soluble Proteins of Avirulent Legionella 
pneumophila After 12% Sodium Dodecylsulfate 
Polyacrylamide Gel Electrophoresis 
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using a 3-27% gradient gel are shown in Figure 26 . This 
time there were no apparent differences in the patterns 
seen between the virulent and avirulent -~ pneumophila. 
Testing the organisms with a direct fluorescent 
antibody reaction using a monoclonal antibody resulted 
in a drop in the number of intensely stained bacteria as 
the cultures grew older (Table 30) The vi rulent strain 
demonstrated only 25% which were as brightly stained as 
the positive control by the eighth day of culture, 
whereas the 8 day culture of the avirulent _k:__ 
pneumophila showed 50% of the bacteria fluorescing this 
intensely. When a polyclonal antibody was used in the 
same reaction, no reduction in intensity was noted for 
either the virulent or the avirulent form 2, 3 , 8, or 17 
d ays after the BCYE plates were inoculated. The 
organisms were not tested at 24 h as originally planned 
because there was little visible growth on the plate 
inoculated with the virulent _k:__ pneumophila. 
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A v 
Figure 26 
Patterns of the Soluble Proteins of Virulent and Avirulent 
~eumophila After Gradient (3-27%) Sodium 
Dodecylsulfate Polycrylamide Gel Electrophoresis 
V = virulent Av = avirulent 
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Table 30 
compari son of Direct Immunofluorescent Reactions of Virulent and 
Avirulent Legionella pneumophila Using Monoclonal or Polyclonal 
Antibody 
Antibody 
Monoclonal Polyclonal 
Age of Culture (Days) 
Virulent Strain 
2 100 100 
3 50 100 
8 25 100 
17 25 100 
Avirulent Strain 
2 100 100 
3 50 100 
8 50 100 
17 50 100 
Bacterial cells in all tests were fluorescent; results are 
expressed as the approximate percentage which were as bright as 
the positive control supplied with each kit. 
DISCUSSION 
Ability of the two strains of~ pneumophila 
serogroup 1 to cause disease was repeatedly confirmed 
throughout this study. The virulent form was able to 
kill most guinea pigs at concentrations as low as 2.6 x 
10 7 CFU/ ml and produce observable signs of infection in 
half the animals at 2.5 x 10 6 CFU/ ml (Tables 3, 4, and 
5) . These values are similar to those reported by 
others (29, 33, 112, 116, 122, 342). It is difficult to 
make direct comparisons owing to the variety of strains 
used as well as differences in culture conditions and 
criteria for infection. Early works also often lack 
data concerning passage history of the isolate(s) used, 
a factor now known to be important in assessing 
v irulence. Intraperitoneal inoculation of the animals 
is also a less sensitive indicator of virulence. 
Infection via aerosol inhalation results in consistent ly 
lower LD5 0 v alues (22, 75) and is probably the method o f 
choice when comparison with h uman disease is des i red. 
This requires more equipment and technical expertise 
t han intraperitoneal inoculation and may not be feasible 
except in large research facilities where many animals 
must be infected. 
Twelve guinea pigs received at least 1 x 10 8 CFU of 
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t he virulent strain. Two animals never developed 
vi sible signs of infection. The possibility that some 
animals may have been exposed to legionellae prior to 
i njection was considered. Four animals were tested for 
antibodies using an indirect fluorescent assay; 
significant titers were not found. This apparently 
random resistance remains unexplained, but is unlikely 
to be due to prior exposure. Animals were outbred so 
variations in innate susceptibility to infection would 
seem to be the best explanation. Variability in 
virulence of the organism can be ruled out since the 
suspension which failed to infect one of the animals was 
lethal for 4 of 4 animals which received a 1:10 dilution 
of this same suspension (Table 5). 
Comparison Studies of EYB and BCYE Media 
Both strains of b_,__ pneumophila were able to grow on 
BCYE and EYB agars. The avirulent, agar-adapted form 
consistently showed visible growth earlier than the 
virulent form, especially when the virulent strain was 
to be isolated from a tissue suspensi on . Both strains 
showed browning and a clear zone in the agar around 
colonies on EYB. This is in agreement with Chan's 
(Ph.D. thesis) results; however, the colonies were 
cream-color in this study as opposed to the sunshine 
yellow, deepening as the colonies aged, seen by him. 
The most obvious explanation is strain differences since 
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Chan used the Knoxville 1 strain rather than Burlington 
1 . The Burlington 1 strains also grew better on BCYE 
than the EYB. In one instance, no visible growth was 
seen on EYB at 72 h, but colonies were seen on BCYE. 
More colonies were seen on BCYE in most instances as 
well. This is in agreement with Keathley and Winn (177) 
who suggested that media without charcoal do not support 
the growth of legionellae as well as those which contain 
it. The charcoal probably removes inhibitors produced 
when yeast-extract containing media are autoclaved 
(154). 
Virulence was maintained for 26 passages on either 
agar (Tables 3 and 4). Chan found that virulence was 
lost after 25 passages on BCYE but not on EYB. Again, 
strain differences may account for this discrepancy as 
well as the small numbers of animals used in both 
studies. Other researchers have found that virulence is 
lost after as few as 5 transfers on modified Mueller-
Hinton agar (103) or 10 on BCYE (33). In contrast, 
others have found no loss of virulence after 12 passages 
on BCYE (103, 338) and some have suggested that 30 
transfers or more may be necessary to produce an 
avirulent variant (163, 257, 313) 
Ability to cause disease may be related to 
variables other than medi a c omponents. In this study, 
apparently random events seemed to result in changes in 
the abil i ty of the v iru lent organi sm to affect guinea 
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pigs. After 20 passages on BCYE, the animal receiving 7 
x 10 8 CFU failed to develop disease, yet 6 additional 
t ransfers resulted in death of another guinea pig 2 days 
a fter receiving 4.7 x 10 8 CFU. Age of the medium was 
suspected, but this was not confirmed when fish were 
u sed as the experimental model (Table 22). Edelstein 
( 89) has suggested incubation temperature may affect 
v irulence. All cultures were incubated at 37C in this 
study and Chan did not find temperature to affect 
v irulence, either. Legionellae require very humid 
conditions for survival and growth (21, 74). Danielson 
and Cooper (74) have suggested that evaporation and 
syneresis associated with agar plates may affect the 
ability of legionellae to grow on laboratory media. 
Their solution is to use a biphasic slant or to incubate 
the inverted petri dishes with sterile water in the 
lids. This may explain the results seen here or other 
undefined changes which occur in preparation and/ or 
storage of media may be responsible. Pine et al. (241) 
suggests the age of either the inoculum or medium or 
both could limit subsequent growth. Solid media may 
select for auxotrophs which requ ire either amino acids 
or purine for growth. These organisms may also be able 
to grow in the presence of compounds inhibitory for the 
more virulent forms. 
Effects of Po l ymixin B Pre-treatment 
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• 
Polymixin B treatment also failed to alter 
virulence . Morphological changes seen on electron 
microscopy were similar to those reported by Chan. 
Blebs were formed in both virulent and avirulent strains 
after exposure to polymixin B (Figures 22 and 23). 
These were evenly distributed over the outer surfaces of 
the bacteria. Size was proportional to antibiotic 
concentration (data not shown). The nuclear material 
was distributed in a patchwork pattern. There was no 
apparent change, however, in the numbers of virulent 
organisms required to produce disease and/or death as a 
result of pre-treatment (Table 5) . Treatment of the 
avirulent strain failed to produce visible signs of 
infection as well (Table 6) The failure to confirm 
Chan's findings regarding increased virulence with 
polymixin B treatment may also be explained by strai~ 
differences and/or the small numbers of animals used in 
each study. Wong, et al. (336) suggested that polymixin 
B treatment results in decreased toxicity through 
binding of the lipid A component of endotoxin. Toxicity 
was not significantly reduced in their experiments using 
mice; this work using guinea pigs would support their 
finding as well. 
Detection of Virulence Factors 
Morphologically, there was l i ttle difference 
between the two strains. The avirulent strain showed 
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hi gher numbers of very long filamentous forms in a Gram 
stained smear. As the cultures aged, the virulent 
strain produced increased numbers of filamentous forms 
but not to the level seen in the agar-passaged strain. 
This is compatible with the findings of Bornstein, 
Nowicki, and Fleurette (33). They studied filament 
length in various culture conditions and related this to 
vi rulence. Bacteria with the longest average length 
also had the highest LD 50 . In vivo findings also would 
support this theory. Short, cocco-bacillary forms are 
mo st often seen in tissue sections while greatly 
elongated forms are rare (54, 250). 
Electron microscopy of isolates showed them to be 
similar as well (Figures 18 and 20) . No flagella or 
pili were noted. This is not unusual; early reports 
failed to note appendages in the several strains 
examined (54, 250). Later studies did reveal the 
presence of flagella (57, 252, 296). The Burlington 1 
strain has been shown to produce streamers and a curly 
polar flagellum when stained using a simplified Leifson 
method (296) . Several groups (102, 252, 296) note that 
passage on artificial media may result in loss of the 
ability to produce flagella and that very gentle 
handling during processing is required to maintain 
attachment to the bacteria. Hebert and associates (141) 
noted that only a small number of cells had flagella in 
their analysis of the OLDA strain of L. pneumophila. 
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Elliott and Johnson (103) demonstrated that loss of the 
ability to produce flagella does not alter the ability 
to produce disease in guinea pigs via intraperitoneal 
injection. This is also the case in the present study. 
In one instance, an aliquot was injected into a guinea 
pig while another portion of the suspension was 
processed for electron microscopy. It is possible that 
flagella were either not being produced or were lost in 
processing. In either case, the virulent strain was 
able to cause disease. 
One difference in the strains was the size of the 
intracellular vacuoles. These vacuoles were smaller and 
usually less distinct in the avirulent form. Chan also 
noted increased vacuolation in forms thought to be more 
virulent. Vacuoles also are easily found in organisms 
seen in human lung tissue (54, 178, 250). It is 
possible that these vacuoles contain products which 
increase the virulence of the bacteria. They are more 
likely, however, to be storage granules produced in 
times of decreased availability of nutrients in the 
environment. As discussed above, the avirulent form is 
able to grow better on artificial media and is probably 
able to utilize more components more efficiently than 
the virulent strain. Chan noted increased vacuolation 
in organisms grown on EYB but not on BCYE. This is 
consistent with this interpretation as in the present 
study organisms did not grow as well on EYB, which would 
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l ead to increased vacuolation if this theory is correct. 
Intracellular organisms in vivo would also deplete 
nutrients as they multiply within the macrophages. 
These granules stain with Sudan black and appear to be 
poly-B-hydroxybutyrate-like (251, 317). This would also 
support the idea that these are storage granules rather 
than enzymes or other factors which would result in 
increased ability to cause disease 
More interesting is the fact that capsules were 
found without much difficulty in the avirulent strain 
(Figure 21). Only 3 cells of the virulent strain were 
noted to have a possible capsule (Figure 19). 
Encapsulation remains a controversial question. Glavin 
and associates (131) suggested that the clear space 
surrounding bacteria they saw in human lung tissue might 
represent a microcapsule or slime layer in some strajns. 
Hebert et al . (141) used ruthenium red to look 
specifically for capsules. Capsules were readily found 
in~ micadei, ~ bozemanii, and~ dumoffii, but were 
rare in the strain of ~ pneumophila examined. Rogers 
and Davey (251) did not observ e c apsules using ruthenium 
red in either organisms in lung cell v acuoles or in 
intact cells grown in the laboratory . They suggest that 
this discrepancy may be due to slight differences in 
technique, strain differences, or the fact that capsules 
occur rarely, if at all, in~ pneumophila (255). The 
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present study found capsules, but most often in the 
avirulent form. 
Capsules are known to increase virulence by 
increasing resistance to phagocytosis (36). Since L. 
pneumophila multiplies only intracellularly, it may be 
that the presence of a capsule actually hinders its 
ability to multiply in the animal host and would thus be 
associated with decreased virulence. The ability to 
survive and multiply within macrophages is associated 
with virulence. Avirulent strains are either killed 
(182) or multiply more slowly and to a lower magnitude 
(313). Jepras et al . (164) found that guinea pigs 
infected with an avirulent strain had mostly 
extracellular organisms on lung lavage The virulent 
strain was found mostly intracellularly in the same 
situation. They suggest that avirulent strains resist 
phagocytosis or are more effectively killed by the 
macrophage following ingestion. The presence of 
capsules would support the first mechanism. 
Plasmids were not seen in eitI'.er strain (Figure 
17). This finding is consistent with other work. Both 
plasmid-containing (96) and plasmidless (29, 46, 47) 
isolates have been associated with outbreaks of LD . 
Plasmid-containing isolates retain them on transfers so 
these are probably most useful as an epidemiologic tool 
(228). The presence or absence of plasmids has no 
apparent relationship to v irulence. 
Polyacrylamide gel electrophoresis (PAGE) results 
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were puzzling. Initial work using a 12% resolving gel 
suggested the presence of bands in the avirulent strain 
not seen in the virulent organisms (Figures 24 and 25). 
This is similar to the work of Reardon (M.S. thesis, 
Virginia Commonwealth University, 1985). He found two 
major bands present in the avirulent strain in addition 
to three bands prominent in both strains. Differences 
in technique (Reardon used an 8% resolving gel) may 
account for the small differences in relative mobilities 
of the major soluble proteins seen in this and Reardon's 
study. Gradient PAGE failed to confirm the differences 
between strains (Figure 26). This method was more 
sensitive; many more bands were discernable. They 
appeared to be identical in relative mobility and 
staining properties in the virulent and avirulent 
organisms. Lema and Brown (192) have compared 
electrophoretic patterns of the soluble proteins from 5 
species as well as 21 strains of 6 serogroups of L. 
pneumophila. They found only minor differences within a 
species and suggested that patterns were distinctive 
enough to allow species identification with SOS-PAGE. 
The~ pneumophila serogroup 1 strains analyzed (13) 
were similar although some demonstrated bands of lighter 
staining intensity suggesting lower production of 
certain proteins. Lema and Brown thought this may 
correlate with the presence of a plasmid, which may 
promote increased synthesis of a peptide. It is 
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difficult to comp~re their band patterns with those seen 
in this work since different methods of preparing the 
specimens and gels were used. Generally, many bands 
could be seen in both, with an apparently heavier 
concentration of low molecular weight proteins. There 
may be minor strain differences, but these are probably 
not related to virulence. The additional bands seen in 
the avirulent strain when the 12% separating gel was 
used could be due to the relative insensitivity of this 
procedure. The virulent organism may produce these 
proteins, but at levels detectable only with the 
gradient gel. Variations in media (see earlier 
discussion) may have led to altered protein production 
which affected the virulent strain to a greater extent 
than the agar-adapted avirulent strain in the 12% gel 
experiments. 
Results of direct fluorescent antibody staining 
were interesting. Both strains stained uniformly and 
with the same intensity as the positive control when the 
polyclonal reagent was used. The number of cells which 
stained as intensely as the positive control decreased 
at 72h of growth when the monoclonal antibody test 
system was used. This remained constant at about 50% 
for the avirulent form but declined to 25% at 8 and 17 
days for the virulent strain (Table 30). All cells at 
all times were fluorescent, but those which did not 
stain as brightly as the positive control diminished in 
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staining intensity as the cultures aged so that at day 
17, 50% of the avirulent cells and 75% of the virulent 
cells were only weakly positive (l+). Cells which were 
brightly stained were primarily the filamentous forms 
which increased in number as the cultured aged. This 
variation in fluorescence intensity with the age of the 
culture is noted in the product information supplied 
with the Genetic Systems reagents. However, they 
describe a lack of uniform staining over the cell 
surface rather than cell-to-cell differences in 
intensity. 
These results support the findings of a study by 
Petitjean et al. (Abstr. Ann. Meet. ICAAC, 1986, 1072, 
p. 293). They found a change in the affinity constant 
and the number of low affinity binding sites as a 
virulent organism was subcultured to produce an 
avirulent derivate. Loss of reactivity with their 
monoclonal antibody was related to loss of virulence. 
In the present study the virulent form lost reactivity . 
These discrepancies are easily explained since different 
monoclonal antibodies were used. Petitjean and co-
workers used an antibody identical to CDC Mab 2, which 
reacts only with subgroups of 1-.:_ pneumophila serogroup 1 
(168). The Genetic Systems monoclonal antibody is 
species-specific and reacts with all strains from the 9 
serogroups tested (133). It is probable that a change 
in the epitope itself or in accessibility to the 
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antigenic determinant occurs as th~ culture fages. 
Increased "stickiness" is seen on aging. This may be 
the result of the production of a slime layer which 
would obscure the antigenic determinant to a greater 
degree in the virulent form. Vigorous mixing did not 
change the reactions, suggesting an alteration in 
individual cells rather than changes as a result of 
increased clumping. The polyclonal reagent contains a 
mixture of antipodies with different specificities which 
may explain the fact that all cells at all ages reacted 
with the same intensity. Certain antibodies in the 
mixture may react differently, but this is not detected 
in microscopic analysis. 
Other investigators have shown that strains of 1-:_ 
pneumophila which give certain patterns when tested with 
a panel of monoclonal antibodies are more likely to be 
associated with clinical illness than other strains with 
different reactivities using the same panel (236, 306, 
319). It is possible that proteins which react (or fail 
to react) with certain monoclonal antibodies are 
associated with virulence. The fact that filamentous 
forms fluoresced to a greater extent using the Genetic 
Systems antibody and may be associated with decreased 
virulence would also tend to support this view. These 
areas require further investigation. 
Fish as an Experimental Model 
145 
Chemotactic assays gave similar results when human 
mononuclear cells, guinea pig peritoneal macrophages, or 
spot kidney macrophages were tested (Table 29). The E. 
coli and the avirulent 1..,_ pneumophila were chemotactic 
for all 3 species. The virulent L. pneumophila resulted 
in minimal chemotactic activity in all three instances 
when 2.5 times the negative control mean was used to 
evaluate this response. Macrophages migrated through 
the filters in greater numbers when virulent 1..,_ 
pneumophila was tested than when only medium was used, 
in suf~icient quantity to result in a positive 
interpretation only with the spot macrophages. These 
findings are similar to those of Horwitz and Silverstein 
(159) who found that phagocytosis of 1..,_ pneumophila in 
the absence of antibody and complement is very 
inefficient. 
Data from the hogchoker and minnow chemotactic 
experiments are different from those discussed above. 
The hogchoker macrophages responded positively to the E. 
coli and the virulent 1..,_ pneumophila but not to the 
avirulent strain. Minnow macrophages were unresponsiv e 
to any of the bacteria tested . It is possible that test 
conditions were not optimal in the case of the minnows . 
A variety of systems was evaluated (data not shown) with 
essentially similar results . It is likely that the 
minnow macrophages do not respond in the same way as 
mammalian cells do. Little is known about the 
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c hemotactic response of macrophages in fish and this 
function only recently has been studied in the hogchoker 
and spot (320). 
In vivo experiments using the 3 species of fish 
were frustrating at times as well as exciting. 
Laboratory conditions were not ideal for long-term 
maintenance of healthy fish. Overcrowding in the 
aquaria was an important problem. Frequent partial 
changes of water and prompt removal of excess food and 
obviously sick fish allowed the survival of all 3 
species in an apparently healthy condition for up to 6 
weeks and possibly longer. Another drawback in the fish 
studies was the fact that when large numbers of fish 
died in a short period of time, the non-specific toxins 
released into the water affected other fish in the same 
aquarium This meant that in a few instances, control 
fish were found dead as well, making results difficult 
to interpret (e.g . , Table 16). Experiments were 
modified so that fewer fish were housed in each aquarium 
when large numbers of deaths were expected. This meant 
that variables might be introduced as a result of 
potential differences in the env ironments of different 
aquaria and/ or that periodic sacrifice of infected fish 
must be limited. 
Once these problems were overcome, the fish prov ed 
to be an acceptable experimental model. Deaths occurred 
within 24 to 48 h which was similar to times noted for 
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the guinea pigs and consistent with those reported by 
other investigators using mammalian models (116, 144, 
257). All species of fish were more resistant to 
infection than the guinea pigs. Virulent 1__,_ pneumophila 
at concentrations of 10 7 CFU was able to kill guinea 
pigs but all species of fish required inoculum sizes 
between 109 and 10 1° CFU before deaths consistently 
occurred. The minnows appeared to be most susceptible; 
the hogchokers the least; and the spot were intermediate 
in susceptibility. In this regard, the fish are similar 
to rats and mice which are also more resistant to 
infection than guinea pigs when injected 
intraperitoneally (83, 101, 257). 
There were some differences in the ability of 
similar numbers of virulent organisms to cause deaths 
(Tables 7, 10, 12, 13, 14, 18, 20, 21) . This is mos~ 
likely to be due to the small numbers of fish used in 
each experiment. Another possibility is the media 
variability discussed earlier. Age of the medium was 
considered but this was not confirmed (Table 22) . Other 
unidentified factors related to the medium may be 
responsible. Analysis o f the data also suggested that 
the volume injected may be related in some way to the 
ability to cause death. The amount of fluid alone is 
unlikely to be responsible (B . A. Weeks, D.Paylor, 
personal communications). It may be t hat a toxin is 
released during the preparati on of the suspension or 
t hat cells are disrupted during the mixing process. 
Thus, more nonviable cell fragments and/or perhaps 
t oxin(s) (either soluble or bound to these cells) would 
be injected as well as viable bacteria as volume is 
i ncreased. Endotoxin alone is unlikely to be 
responsible, as the Legionella endotoxin is atypical and 
weak in in vivo tests (366). Rolstad and Berdal (257) 
suggest that in the rat, intracellular multiplication is 
not required to produce pathologic changes. If their 
animals were affected, they died rapidly (within 24 h) 
and they suggest that the rat is responding to a toxin 
or other virulence factor only, whereas the guinea pig 
is also susceptible to the effects of bacterial 
multiplication within the macrophage. The results shown 
here suggest that this may be important in the fish as 
well. 
Some fish did die after injection with the 
avirulent strain, although not in the numbers that those 
which received the virulent organisms did. No cross-
infection among fish is likely as legionellae were never 
isolated from control fish . This is compatible with a 
difference in amount or type of virulence factors 
produced. Fish which d i ed more than 48 h after 
injection appeared to do so in a random manner. This 
also supports the theory that intracel lular 
multiplication is not prominent in the f i sh as a 
pathogenic mechanism . Viable bacteria were isolated in 
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apparently healthy fish of all three species. The 
bacteria may survive within the fish and possibly 
multiply, but with no apparent ill effects. 
Guinea pigs infected intraperitoneally with 
virulent Legionella often are found to have a peritoneal 
exudate. This did not appear to be the case with the 
spot. Spot injected with the avirulent strain had more 
leukocytes in Wright-Giemsa stained peritoneal smears 
than either the controls or those receiving the virulent 
strain. Mononuclear cells predominanted with few 
granulocytes seen (Figures 7, 8, 9, 10, and 11). These 
mononuclear cells were mostly lymphocytes and 
macrophages with occasional plasmoid lymphocytes and 
plasma cells . These findings are compatible with the 
chemotactic studies, which suggested that the avirulent 
organisms were more chemotactic in vitro (Table 27). 
Sheets of mononuclear cells were also seen in the spot 
receiving the virulent bacteria (Figures 14, 15, and 
16). These cells had rounder nuclei with a more open 
chromatin pattern and indistinct cytoplasmic borders. 
These are most likely mesothelial lining cells rather 
than macrophages. Similar sheets also occasionally were 
seen in controls as well as fish inoculated with the 
avirulent strain. These results must be considered 
preliminary as only a few fish were examined. 
Degenerative changes were prominent in fish found dead; 
fish should be sacrificed at interv als and smears 
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examined to verify these findings. 
Isolation of viable bacteria from all three species 
is interesting. Hogchokers cultured up to 14 days after 
inoculation (Tables 8, 9, 11), spot up to 7 days (Table 
11), and minnows up to 10 days had positive cultures . 
Whether the bacteria actually multiplied or only 
survived in the peritoneal cavity cannot be determined 
from the data. In several instances, the fish were 
apparently healthy and were sacrificed rather than 
cultured after death. The minnows had fewer organisms 
than either the hogchoker or spot. Fish which come into 
contact with legionellae or amoebae containing them in 
the environment may become infected and serve as 
additional reservoirs for the bacteria during adverse 
conditions. Legionellae have not been isolated from 
salt water (118) but evidence exists that birds 
associated with the ocean can be infected (65). It is 
possible that estuarine fish such as the hogchoker or 
spot may protect the legionellae from the effects of 
salt water as well as provide a means for wider 
dissemination of the bacteria. Both freshwater as well 
as marine fish should be captured and cultured from a 
variety of sites to test this hypothesis. 
In summary, virulence of L. pneumophila is most 
likely a result of a combination of toxin production and 
intracellular multiplication in susceptible cells . 
Comparison of the virulent and avirulent forms of the 
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Burlington 1 strain of b....:_ pneumophila demonstrated that: 
1) virulence is maintained for at least 26 passages on 
either EYB or BCYE media, but appears to be 
affected by unknown medium-related variables. 
2) polymixin B treatment does not affect either 
strain's ability to cause disease in guinea pigs 
inoculated intraperitoneally . 
3) morphologically, the avirulent strain produces more 
filamentous forms and possibly is encapsulated more 
frequently . 
4) virulence is not related to the presence of a 
plasmid and is unlikely to be a result of 
production of proteins separable by SDS-PAGE. 
5) v irulent cells react less i ntensely with monoclonal 
antibody in the DFA test as they age probably as a 
result of concealment, alteration or loss of the 
antigenic determinant. 
6) the avirulent strain is more generally chemotactic 
for macrophages although neither is potent in this 
respect . 
7) estuarine and freshwater fish may be additional 
environmental reserviors and can serv e as 
experimental models in the e v aluati on of certain 
properties of b....:_ pneumophila. 
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APPENDIX A 
Buffered Charcoal Yeast Extract Agar (BCYE) 
BCYE dehydrated media* 19.15 g 
L-cysteine HCL • H 0 
2 
0 . 2 g 
Suspend BCYE in 450 ml of deionized water. Adjust to pH 
6.9 with IN KOH. Add enough water to bring the 
total volume to 495 ml. 
Autoclave at 121 C for 15 min and cool to 50 C. 
Prepare a fresh solution of L-cysteine ( 0 . 2 g in 5 ml of 
water), sterilize by filtration (0 . 2 µm mill i pore 
filter** ) and add to cooled basal medium. 
Mix well and pour into petri dishes . 
* Gibco Diagnostics, Lawrence, Massac husetts 08143 
**Gelman Sciences, Inc., Ann Arbor, Michigan 48106 
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Egg Yolk Buffered Agar (EYB) 
Yeast Extract* 10 g 
ACES Buff er 10 g 
Agar* 17 g 
8.0 N KOH 5 ml 
L-Cysteine HCL • ~ 0 0.4 g 
Ferric pyrophosphate 0.25 g 
50% Egg yolk suspension* 10 ml 
Add yeast extract, ACES buffer and agar to 965 ml of 
deionized water. 
Autoclave at 121 C for 15 min, then cool to 50 C. 
Prepare fresh solutions of L-cysteine (0.4 g in 10 ml of 
water) and ferric pyrophosphate (0.25 g in 10 ml of 
water). 
Filter KOH, L-cysteine, and ferric pyrophosphate 
solutions through a 0.2 µm filter (Gelman) and add 
to cooled basal medium. Add the egg yolk 
suspension, mix well, and pour into petri dishes. 
*Difeo Laboratories, Detroit, Michigan 48232 
212 
213 
Semi-Selective Medium (BMPA...<.)* 
BCYE dehydrated media (Gibco) 19.15 g 
Agar (Difeo) 5 g 
L-Cysteine HCL • H 0 
2 
0.2 g 
Polymixin B 80 µg / ml 1. 0 ml 
Anisomycin 80 µg / ml 1. 0 ml 
Cefamodole 4 µg/ ml 1. 0 ml 
Suspend BCYE agar in 450 ml deionized water. Adjust to 
pH 6.9 with IN KOH. Add enough water to bring the 
total volume to 493 ml. 
Heat to boiling to dissolve; then autoclave at 121 C for 
15 min and cool to 50 C . 
Prepare a fresh solution of L-cysteine (0 2 g in 5 ml of 
water). Filter all solutions through a 0.2 µm 
millipore filter (Gelman) to sterilize and add to 
cooled basal medium. 
Mix well and pour into petri dishes. 
*Edelstein, J . Clin. Microbial 14 : 298-303, 1981 (85) . 
Yeast Extract Buffered Broth (YEBB) 
Yeast Extract (Difeo) 
ACES Buff er 
8.0 N KOH 
L-Cysteine HCL • H z° 
Ferric pyrophosphate 
10 g 
10 g 
5 ml 
0 . 4 g 
0.25 g 
Add yeast extract to ACES buffer to 975 ml of deionized 
water. 
Autoclave at 121 C for 15 min, then cool to 50 C. 
Prepare a fresh solution of L-cysteine (0.4 g in 10 ml 
of water) and ferric pyrophosphate (0.25 g in 10 ml 
of water) . 
Filter all solutions through a 0 . 2 µm millipore filter 
(Gelman) to serilize and add to cooled basal 
medium. 
Mix well and dispense into 100 ml bottles. 
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APPENDIX B 
Solutions Used in Plasmid Analysis 
1. Schlae's TE buffer (0 . 05 M Tris HCl, 0.01 M EDTA). 
Combine 4 g Tris HCl with 1.86 g EDTA; bring to 500 
ml with distilled water; and adjust to pH 8.0 with 
glacial acetic acid. 
2. ~ysing buffer (SO mM Tris, 3% SDS). 
Dissolve 1.5 g Tris acetate and 7.5 g SDS in 250 ml 
distilled water; adjust to pH 12.6 with 3N NaOH. 
3. 20% sodium dodecyl sulfate (SDS). 
Dissolve 2.0 g SDS in 10 ml distilled water. 
4. 10 X E Buffer. 
Add 97 g Tris acetate to 13 g EDTA; mix with 2 1 of 
distilled water; adjust to 7.9 with glacial acetic 
acid. Dilute to 1:10 for 1 XE buffer (40 mM Tris 
acetate, 2 mM EDTA). 
5. Sample buffer. 
Mis 5 ml 10 X E buffer with 5 ml glycerol, 350 µl 
20% SDS and 7 mg bromophenol blue. 
6. 0.6% agarose. 
Combine 1.5 g agarose with 250 ml of 1 X E buffer; 
bring to a boil to dissolve; then cool to SO C. 
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Solutions Used in Polyacrylamide Gel Electrophoresis 
1. Lower gel buffer (1.5 M Tris, 0.4% SDS). 
Combine 36.33 g Tris and 0.80 g sodium 
dodecylsulfate (SDS); bring to 200 ml with 
distilled water; adjust to pH 8.8 with lN HCl; 
store at 4 C up to one month. 
2. Stacking gel buffer (o.5 M Tris, 0.4% SDS). 
Combine 6.06 g Tris and 0.40 g SDS; bring to 100 ml 
with distilled water; adjust to pH 6.8 with lN HCl; 
store at 4 C up to one month . 
3. Acrylamide solution. 
Combine 58.4 g acrylamide, 1.6 g bis-acrylamide and 
140 ml distilled water; filter using a 0.22 micron 
vacuum filter (Falcon Plastics, Oxnard, California 
93030); store in a brown bottle at 4 Cup to one 
month. 
4. Stock running buffer (0.25 M Tris, 1 . 92 M glycine, 
1% SDS). 
Combine 30 3 g Tris, 144.0 g glycine, and 10 . 0 g 
SDS; bring to 1 1 with distilled water; store at 
room temperature up to one month. Dilute 1:10 with 
distilled water just before use. 
5. Sample buffer (0.0625 M Tris, 2.3% SDS, 0.05% 
bromphenol blue). 
Combine 0.1892jTris, 0.575 g SDS, 0.0125 g 
bromphenol blue, 2 . 5 ml glycerol, and 21.91 ml 
distilled water; adjust to pH 6.8 with 1 N HCl; 
store in 1 ml aliquots at 4 C up to one month. 
Allow to come to room temperature and add 50 µl of 
2-mercaptoethanol per ml just befo re use. 
216 
Publications 
Sommer, Sandra R., The Ivy Bleeding Time Procedure (The 
Mielke Modification), videotape cassette, 6 min. 30 sec. 
viewing guide, 7 pages, produced by the Visual Education 
Department, 1976 , revised, 1977. Recommended in AVLINE. 
Recommended and distributed by the Health Sciences 
Consortium, Inc. 
Sommer, Sandra R., Hemostasis, Package I: The Role of 
Blood Vessels and Platelets, instructional monograph, 20 
pages, 7 slides, produced by the Visual Education 
Department, 1978, revised, 1981. Recommended and 
distributed by Health Sciences Consortium, Inc. 
Sommer, Sandra R., Hemostasis, Package II: Coagulation, 
instructional monograph, 34 pages, 7 slides, produced by 
the Visual Education Department, 1978, revised, 1981 . 
Recommended and distributed by Health Sciences 
Consortium, Inc. 
Sommer, Sandra R., Hemostasis , Package III: 
Fibrinolysis/ Homeostatic Controls, instructional 
monograph, 18 pages, 3 slides, produced by the Visual 
Education Department , 1978, revised, 1981. Rec ommended 
and distributed by Health Sciences Consorti um, Inc. 
Sommer, S. "Hematology Case Study," The Virginian 
Technoscope, Decmeber, 1985, p . 10. 
Contributor , NCA Rev iew for the Clinical Laboratory 
Sciences, Bender, J. L., editor, 1985. 
Weeks, BA; Sommer, SR; and Dalton, HP. 1987. 
"Chemotactic Response of Spot Macrophages t o Legionella 
pneumophila : Correlation with Pathogeni c i t y." J. Fish 
Dis .: in press. 
Abstracts 
Sommer, S . ; Escobar, MR; and Dal ton, HP. 1974. 
"Studies on the bacteri ophages o f Pseudomonas 
pseudomallei". Bacterial Proc. 74 . 
Sommer, S; Escobar, MR; Dalton , HP; and Allison, MJ. 
1974 . "Viral identification by immunoelec tro-
osmophoresis (IEOP)." Bacte r ial Proc. 7 4 . 
218 
